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Abstract
Boron Neutron Capture Synovectomy (BNCS) has been proposed as a novel application
of the o1 B(n,a) 7Li reaction for the treatment of Rheumatoid Arthritis (RA). RA is an
autoimmune disease of the joints characterized by an inflammation of the synovium, the
membrane lining the joint capsule. If drug regimes fail, treatment options are surgical syn-
ovectomy or radiation synovectomy. BNCS has advantages over these treatment
approaches in that it is non-invasive and does not require the administration of radioactive
substances. In BNCS, a o1 B labelled compound would be injected into the fluid space of
the joint where it would be taken up by the synovium. The joint would then be irradiated
with neutrons causing intense radiation damage to be delivered to the boron loaded cells.
This thesis had two major goals. The first was to conduct an investigation of in vitro
uptake of ' 0B by human RA synovium and RA and osteoarthritic cartilage samples, thus
allowing an estimate of levels potentially attained in vivo. The primary boron compound
investigated was K2B, 2Hz1 , although some studies were also done with boric acid and
boron particulate. Quantification of bulk uptake was performed using Prompt Gamma
Neutron Activation Analysis. Cell kill as a result of the boron neutron capture reaction
was verified by thermal neutron irradiation of boron-loaded tissue. An attempt was made
to determine the spatial distribution of the boron compound using Neutron Induced Alpha
Track Autoradiography. The second major aim of this thesis was to design an accelerator-
based neutron beam for BNCS using the Monte Carlo for Neutron and Photon Transport
code. A computational model of a knee joint was developed and the therapeutically useful
neutron energy range was established by a series of ideal beam studies. A comparison was
made between two neutron producing reactions for an accelerator source. Since neutrons
coming from an accelerator source are very energetic and thus need moderation to the
therapeutically useful neutron energy range, moderator/reflector configurations were
examined. Materials for the moderator/reflector assembly were chosen and preliminary
configurations were assessed in terms of their potential clinical usefulness in the joint
phantom.
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1 Introduction
Boron Neutron Capture Synovectomy (BNCS) has been proposed as a novel application
of the 'oB(n,') 7Li reaction for the treatment of Rheumatoid Arthritis (Johnson et al, 1994).
Rheumatoid Arthritis is an autoimmune disease of synovial joints characterized by inflam-
mation of the synovium, the membrane lining the joint. If left untreated, chronic synovial
inflammation eventually leads to enzymatic destruction of the joint cartilage. Although the
causes of cartilage destruction are not completely understood, it has been established that
proliferation of the inflamed synovium plays an important role (Calabro, 1986).
The primary treatment for Rheumatoid Arthritis (RA) consists of the administration of
drugs to reduce synovial inflammation. However, a single joint may remain unresponsive
and thus require physical removal of the inflamed synovium (Mori, 1985). Removal of the
inflamed synovium, termed synovectomy, has been shown to alleviate symptoms of RA
for periods up to 5 years (Shortkroff et al, 1993). Currently existing options include surgi-
cal procedures and the injection of beta-particle emitters into the joint.
BNCS is a binary therapy approach. It has advantages over surgery and the injection of
beta-particle emitters in that it is non-invasive and does not require the administration of
radioactive materials. In BNCS, first a 1oB labelled compound would be injected into the
fluid space of the joint where it would be taken up by the synovium. The joint would then
be irradiated with neutrons causing intense radiation damage to be delivered to the boron
loaded cells.
Preliminary work has demonstrated that very high '0B concentrations can be obtained in
the synovial lining in vitro (Johnson et al, 1994). In these preliminary studies, 1oB uptake
concentrations by human RA synovium were measured using both a boron particulate and
boric acid. With the boron particulate, IoB uptake averaged 860± 250 ppm for a 1 hour
incubation and 2300+ 1600 ppm for a 24 hour incubation. The concentrations measured
with the boric acid and same incubation times were 188±28 ppm and 244+_37 ppm,
respectively.
This thesis had two major goals. The first was to analyze in vitro uptake of IoB by samples
of human RA synovium and RA and osteoarthritic cartilage. This is important in order to
get some idea of the levels potentially attained in vivo. The analysis performed included
the determination of bulk tissue uptake and spatial distribution of the boron compound,
K2B12H12, as well as verification of cell kill following thermal neutron irradiation of
boron-loaded tissue samples. Quantification of bulk tissue uptake of o1 B was performed
using the Prompt Gamma Neutron Activation Analysis Facility at the MIT Research
Reactor (Harling et al, 1993). In order to verify cell kill as a result of the boron neutron
capture reaction, samples of synovium and cartilage were incubated in boron-containing
medium, irradiated and histology was performed. The spatial distribution of boron uptake
by RA synovium was investigated using Neutron Induced Alpha Track Autoradiography,
a technique which has been used to obtain quantitative information (Liu, 1989) as well as
information on spatial distribution (Abe et al, 1986).
The second aim of this thesis was to design an accelerator-based neutron beam for BNCS
using the MCNP code (Monte Carlo for Neutron and Photon Transport) (Briesmeister,
1986). Although based on the same nuclear principles as Boron Neutron Capture Therapy,
a very different neutron beam design was required for BNCS as a result of the fairly shal-
low depth of the synovial lining and the large concentrations of boron likely to be avail-
able in the synovium. The therapeutically useful neutron energy range for BNCS was
determined through a series of ideal beam studies. Then, since neutrons coming from the
accelerator will be very energetic and thus need moderation to the therapeutically useful
neutron energy range, a moderator and reflector assembly was designed. The effects of
different moderator/reflector dimensions were examined in a tissue-equivalent model of
the knee joint and examples will presented. Also, a comparison was made between two
neutron producing reactions.
The organization of this thesis is as follows. Chapter 2 will present an in-depth discussion
of BNCS and RA. Chapters 3 and 4 will present the methods and results of the in vitro
analysis of IoB uptake, respectively. The details of the beam design will be presented in
Chapters 5 and 6. Conclusions will be drawn at the end, in Chapter 7.
2 Boron Neutron Capture Synovectomy
In this chapter, the characteristics of Rheumatoid Arthritis and current treatment options
are described. The details of BNCS will then be presented, including a discussion of the
'OB(n,a) 7Li reaction, the cornerstone of the therapy. Finally, a comparison will be drawn
between BNCS and BNCT.
2.1 Rheumatoid Arthritis
Rheumatoid Arthritis (RA) is a chronic autoimmune disease of the synovial joints which
is characterized by an inflammation of the synovium. If left untreated, RA could lead to
significant pain with joint deformation and disability. Approximately 1% of the US adult
population is affected by RA (Harris, 1993). Women are affected about three times more
often than men and roughly 80% of all RA patients develop the disease between the ages
of 35 and 50 (Harris, 1993). The prevalence of RA in women compared to men diminishes
as age increases, i.e. men and women become equally affected.
RA affects synovial joints by causing inflammation of the synovium. The synovium is
among the principal structures found in a synovial joint. In a synovial joint the ends of two
bones are covered with a thin layer of smooth and spongy articular cartilage which is the
actual load bearing surface of the joint. Fluid space serves as a lubricant for the cartilage.
This fluid is secreted and maintained by the synovium.
Among other functions, the synovium provides an unobtrusive, low-friction lining for the
joint, and aids in joint stability. For the remainder of this thesis, the synovium will be
described as having two components; the sub-synovium, a vascularized fibrous tissue
composed of collagen and elastic fibers in a wide-meshed surface and the synovial lining
(used interchangeably with the word synovium).
The precise cause of RA, or the trigger of the autoimmune response, is unknown. As the
autoimmune response becomes more organized and the inflammation increases, new
blood vessels develop in the synovium. These are essential to the progression of RA since
the blood vessels are the means whereby nutrients are delivered to the rapidly proliferating
synovial lining cells. It has been well established that they play an important role in RA
(Calabro, 1986).
As shown in Figure 2.1, chronic synovial inflammation eventually leads to enzymatic
bone and cartilage destruction.
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Figure 2.1: If left untreated, RA, characterized by inflammation of the synovium,
can lead to bone and cartilage destruction and eventually to loss of joint function.
The majority of the destruction takes place when the proliferating synovium begins to
invade the joint, i.e. there is an extravagant growth of the synovial lining cells. A tissue
front develops and grows to form finger-like projections which then spread to cover the
articular cartilage lining the joint.
Little cartilage destruction is necessary to weaken normal function of the synovial joint
causing progressive and irreversible articular cartilage disintegration as a result of normal
joint movement. Once destruction of articular cartilage is underway, attempts to protect
the joint are considered to be futile (Lipsky, 1990).
The primary treatment for RA involves the administration of various drugs to reduce the
synovial inflammation. These include aspirin, nonsteroidal anti-inflammatory agents, low
doses of antimetabolites, steroids, remission inducing agent and intra-articular injections
of corticosteroid. While for the majority of patients the symptoms of RA can be controlled
satisfactorily with the variety of drug regimens currently available, a single joint may
remain unresponsive thus requiring the physical removal of the synovium, a procedure
termed synovectomy (Mori, 1985).
A current option for synovectomy is surgery. In this procedure the membrane is excised by
either open or arthroscopic synovectomy. Surgical removal has been shown to provide
relief of pain for 2 to 5 years (Shortkroff et al, 1993). However, several drawbacks to sur-
gery exist. One is the technical difficulty involved in completely removing the synovium
which is due to the complex geometry of the joint (Zuckerman & Sledge, 1985). Other
drawbacks to surgery include inherent dangers in the procedure such as infection and
anesthesia. Also, often hospitalization and prolonged rehabilitation are required.
The other existing option for synovectomy is the injection of beta-particle emitters into the
joint, termed Radiation Synovectomy (Shortkroff et al, 1993). The injected radionuclide is
incorporated into a large molecule such as a colloid which is then rapidly taken up by the
synovial lining through phagocytosis and delivers approximately 10,000 rad (a dose
empirically determined to provide symptomatic relief) to the synovium within a period of
hours to weeks. Since the sub-synovium and synovium together have a thickness on the
order of mm, the beta-emitters chosen are those which deposit the majority of their energy
within 1 to 10 mm in tissue.
Radiation Synovectomy avoids the dangers of surgery and has reported success rates as
high as 80% (Deutsch et al, 1993). However, its primary drawback is the delivery of dose
to non-target organs. This is due to leakage of the radionuclide-containing compound from
the joint cavity. Investigators have found leakage from a few percent to 60% of the
injected dose resulting in unacceptable doses to the liver, spleen and lymphatic system
(Shortkroff et al, 1993). Although Radiation Synovectomy is widely practiced in Austra-
lia, Canada and some parts of Europe, it has not gained acceptance in the US due to con-
cern over the leakage of the beta-particle emitters from the joint to other organs
(Shortkroff et al, 1993).
BNCS, which will be described below, has the potential of eliminating the drawbacks of
surgical and radiation synovectomy. Unlike surgery it is non-invasive and unlike radiation
synovectomy, it does not require the administration of radioactive compounds.
2.2 Principles of BNCS
The crux of BNCS lies in the 1oB(n,a) 7Li reaction. A naturally occurring isotope of boron,
IoB has one of the highest thermal neutron capture cross sections of the non radioactive
elements. Figure 2.2 illustrates the complete sequence of nuclear events in the 'lB(n,a)7Li
reaction.
7Li + oa + 2.79 MeV (6%)
7Li + cc + 478 keV y + 2.3 MeV (94%)
Figure 2.2: Sequence of nuclear events of the 10B reaction with thermal neutrons
The capture cross section of ' 0B is 3837 barns for neutrons with energies of approximately
0.025 eV. The total Q-value for the reactions is 2.79 MeV.
The particles released in this reaction are high "Linear Energy Transfer" (LET) which
means that they give rise to closely spaced ionizations in sharp tracks; the particles have a
range of less than 10 gim (on the order of the diameter of a cell). This theoretically limits
the radiation effects to those cells previously loaded with boron (Barth et al, 1992) The
released particles also have a high Relative Biological Effectiveness (RBE) which implies
that they are more effective than x-rays at cell kill.
In order to minimize dose to non targeted cells and tissues, '0B concentrations delivered to
the target tissue should be as large as possible so that the neutron fluence can be kept as
small as possible. This is desired in order to maximize the dose delivered to the target cells
via the 0oB(n,a)7Li reaction and minimize the dose to non-target tissue through such reac-
tions as elastic scattering of fast neutrons and capture of thermal neutrons.
BNCS involves a two-part procedure. First a boron-labelled (non-radioactive) compound
would be injected into the joint fluid space where it would be taken up by the synovium
The joint would then be irradiated with neutrons, which must be thermal or near-thermal
at the synovium to cause the 10B(n,a) 7Li reaction to occur. This process is schematically
shown in Figure 2.3. The two high-LET, high-RBE particles released by the boron neutron
capture reaction travel distances less than the diameter of a cell and thus deliver intense
radiation damage to those cells previously loaded with boron (Barth et al, 1992). One
major advantage of this type of system is that the two components can be manipulated
independently.
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Figure 2.3 Schematic showing the binary nature of BNCS
(2) neutron irrac'
Taken individually, the two steps in BNCS, i.e. the injection of a compound for the
destruction of the synovium and the irradiation of a target area with neutrons, are not new
ideas. The principle behind radiation synovectomy is to inject a substance, which happens
to be radioactive, into the fluid space for the purpose of destroying the synovium. In
BNCS, however, the compound that is injected into the joint is not radioactive and does
not alone destroy the synovium. The concept of irradiating a target area previously loaded
with '0B is essentially the same as Boron Neutron Capture Therapy (BNCT) except that in
BNCT tumors are generally the targets whereas the target in BNCS is the synovium. How-
ever, the combination of these two steps for the treatment of RA is novel and has never
been tried before.
2.3 Comparison to BNCT
Although the physical principles of BNCT and BNCS are the same, the basic therapy
parameters and requirements are significantly different as a result of the nature and depth
of the target tissue. The target tissue in BNCT is tumor which typically lies several cm
below the surface of the skin while in BNCS the target tissue is the synovium which lies
from 1.3 to 1.5 cm below the surface of the skin.
The method of boron compound delivery to the target tissue differs between BNCT and
BNCS. In BNCT, the boron-labelled pharmaceutical is administered intra-arterially or
orally and must reach the tumor via the body's metabolic pathways. In BNCS, on the other
hand, the method of delivery of the boron compound is by local injection, making it likely
that relatively high concentrations can be achieved in target tissue. Preliminary work has
shown that concentrations ranging from 10 to 100 times higher than those achieved in
BNCT are readily achieved in vitro using a particulate (Johnson et al, 1994).
The above differences will have a profound effect on the required neutron beam energy
range for BNCS. The rationale behind the design of epithermal beams for BNCT is that
the neutrons in the beam need to be energetic enough so that by the time they reach the
tumor they will have been moderated to thermal energies, i.e. energies at which the cross
section for the 'OB(n,a) 7Li reaction is highest. However, this rationale is not applicable to
BNCS due to the shallow depth of the synovium. A full investigation of the neutron beam
energy requirements for BNCS is needed. This was performed as a preliminary step
method in the neutron beam design process. Naturally, a different therapeutically useful
neutron energy range will give rise to a different neutron beam design.
The difference in the size and location of the area to be irradiated will affect the neutron
beam design. In BNCT the target is typically a brain tumor and current thinking says that
it is best to irradiate the whole head in order to get any occult cells, thus implying that the
neutron beam should be comparable to the head in size. In BNCS the target is a joint
which can vary in size (although generally remains smaller than the head). Also, whereas
in BNCT there are many radiosensitive organs near the irradiation area, the joints most
commonly involved in RA are far away from the brain, chest and trunk, furthermore
implying that the neutron beam design for BNCS will differ from that of BNCT.
Finally, unlike BNCT which, as previously mentioned, was designed for patients with
malignant and terminal cancers, the patients in BNCS are otherwise healthy individuals.
This implies that the limits on acceptable radiation dose to healthy tissue will be much
more stringent for BNCS than they are for BNCT.
3 In Vitro Analysis of Boron-10 Uptake: Methods
This chapter will describe the methods used to perform in vitro analyses of JOB uptake by
both synovium and cartilage samples. Information on bulk tissue uptake was obtained via
Prompt Gamma Neutron Activation Analysis (Harling et al, 1993). Cell kill via delivery
of intense radiation dose to cells previously loaded with boron was verified by irradiating
samples in the thermal beam port (2PH2) of the MIT Research Reactor. An attempt was
made to obtain spatial information on boron uptake in tissue using Neutron Induced Alpha
Track Autoradiography.
However, before embarking on a detailed description of the methods, attention will be
drawn to the boron compound primarily used in this thesis, K2B12H12. It is a salt form of
the polyhedral closed form of the borane anion, BnHn2- which is among the best studied
and most stable anion (Cotton & Wilkinson, 1985). It must also be noted that the boron in
the compound was natural, i.e. unenriched in 'oB. Since natural boron only contains 20%
o1B, all incubation concentrations could be increased by a factor of five using a compound
100% enriched in o1 B.
Use of this compound was part of an effort to optimize the chemical form and conditions
of boron delivery to the synovium. Eventually, BNCS will require a 10B-labelled com-
pound which is non-toxic, remains sufficiently long in the joint space and delivers large
amounts of IoB to the synovium. This thesis examined the delivery of 10B to the synovium
while future work will examine the toxicity of the compound and the length of its stay in
the joint space.
3.1 Prompt Gamma Neutron Activation Analysis
Neutron Activation Analysis in general is aimed at quantifying the elemental composition
of materials. Sample irradiation results in the production of gamma emitters whose
gamma rays are used to identify the concentrations of the radionuclides. When sample
irradiation and spectroscopic analysis are conducted simultaneously, the technique is
called Prompt Gamma Neutron Activation Analysis. Since determination of the activity is
dependent on a wide variety of variables some of which fluctuate during the course of the
measurement, standards must be used and a calibration curve constructed. Analysis of °OB
content by prompt gamma neutron activation analysis is dependent upon the detection of
the 478 keV gamma-ray emitted from the excited state of 7Li.
Prompt Gamma Neutron Activation Analysis has been used by investigators in BNCT for
the determination of IoB in animal tissue samples (Fairchild et al, 1983) and was in fact
used for the BNCS preliminary in vitro studies (Johnson et al, 1994). Resolution for this
technique is on the order of 1 ppm which is adequate for the concentrations achievable in
BNCS. The technique was chosen particularly in light of the facility constructed at MIT
(Harling et al, 1993) and the satisfaction of resolution and reliability requirements.
The Prompt Gamma Neutron Activation Analysis Facility at the MIT Research Reactor
produces a diffracted neutron beam with reduced fast neutrons and core gamma-rays at the
sample (Harling et al, 1993). A well moderated beam of thermal neutrons emerging from
the reactor's reflector is incident on a multilayered graphite monochromator which dif-
fracts the beam by 210 . A simplified schematic is shown in Figure 3.1. The neutron beam
with an energy of 0.0143 eV is passed through a sapphire crystal which transmits 80% of
the 0.0143 eV neutrons, less than 1% of the epithermal neutrons, 0.5% of the fast neutrons
and 3 to 20% of the gamma rays in the energy range of 1 to 6 MeV. Collimators are used
resulting in a beam of neutrons with an energy of 0.0143 eV, a flux of 6x10 6 n/cm2s and a
diameter of 1 to 2 cm (Harling et al, 1993). A 122 cm 3 n-type solid state Germanium
detector is positioned at 900 and its sides are lined with 7.5 cm of lead and 4 cm of lithium
carbonate. The lead reduces the effects of stray neutrons and the background count of scat-
tered gamma-rays. The end of the detector is shielded from stray neutrons by 1.25 cm lith-
ium carbonate enriched in 6Li. A Canberra Series 85 multichannel analyzer is used for
spectroscopic analysis. (Harling et al, 1993)
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Figure 3.1 Schematic of the MIT Prompt Gamma Neutron Activation Analysis
Facility (adapted from Harling et al, 1993).
3.1.1 General procedure
For each sample, the count rate of gamma-rays coming from both the hydrogen capture
reaction (2.2 MeV) and the boron neutron capture reaction (478 keV) was determined by
measuring the area under the appropriate gamma peak and dividing by the irradiation
time. The background counts for the gamma-rays resulting from the hydrogen capture
reaction were measured by counting an empty teflon vial while the background rate for the
gamma-rays resulting from the boron neutron capture reaction was measured by counting
a teflon vial filled with deionized water, under the assumption that the boron content of
deionized water and soft tissue were similar.
The count rates for both the boron and hydrogen neutron capture reactions were obtained
in order to calculate the 10B/iH ratio (B/H ratio) which was then used to calculate the IOB
concentration. Using this ratio reduces the effects of inconsistent sample positioning in the
beam and variations in the thermal neutron flux during the measurement.
The calibration curve, relating B/H to boron concentration, was constructed each time
Prompt Gamma Neutron Activation Analysis experiment was performed. Fresh standards
were used each time although the actual standard preparation was only done once.
3.1.2 Preparation of standards for calibration
The preparation of the standards was divided in two parts; the preparation of the mother
solution, 1500 ppm 'lB, and the daughter solutions, 750 ppm, 300 ppm, 150 ppm, and 30
ppm. The preparation of these standards, in that order, will be described below.
(a) Preparation of the mother solution
It has been determined that in order to produce a 100 ppm solution of 'oB solution
3.104165 g of boric acid standard must be added to 1000 ml solution of a mixture which is
composed of one third saline and two thirds deionized water (Chabeuf, 1993). This was
scaled in order to produce 10 ml of a 1500 1oB ppm solution. Thus, it was necessary to add
4.6562 g of boric acid standard (Boric Acid 951 from the National Institute of Standards
and Technology, Gatherburg, MD 20899).
In the first step, the mixture solution was created; 50 ml of saline and 150 ml of deionized
water were combined. A light plastic boat was weighed and the 4.6562 ±0.001 g of boric
acid were added in order to produce a 1500 ppm solution of 10B.
(b) Preparation of the daughter solutions
These were prepared by using the following formula:
K I V 1 = K2 V2  (Eq. 3.1)
where K1 is the original concentration (ppm), V1 is the unknown volume (ml), K2 is the
desired concentration (ppm) and V2 is the desired volume (ml). For example: in order to
obtain 10 ml of 750 ppm solution out of the 1500 ppm mother solution, the above equation
becomes
1500 - V1 = 750 10
which can be solved to yield
V1 = 5ml
This means that 5 ml of the 1500 ppm solution must be added to the mixture of saline and
deionized water (more specifically composed of one third saline and two thirds deionized
water). This yields 10 ml of 750 ppm solution.
The following table summarizes the preparations.
Table 3.1: Summary of daughter solution preparations
Conc. (ppm) mother sol. (ml) mix. sol. (ml)
750 5.0 5.0
300 2.0 8.0
150 1.0 9.0
30 0.2 9.8
3.1.3 Analysis
The B/H ratio was determined for all samples using the following equation
B t  Bn - B0
- n (Eq. 3.2)Ht Hn -HO
where Bn is the count rate of the gamma-rays from the boron neutron capture reaction, Bo
is the associated background count, Hn is the count rate of the gamma-rays from the
hydrogen capture reaction and Ho is its background.
The error in the B/H ratio was calculated in a series of steps. However, first, it must be
noted that the error in the number of counts under the gamma peaks resulting from the
boron and hydrogen neutron capture reactions was given by the multichannel analyzer
which calculates the error assuming a Gaussian distribution. However, the "boron" peak,
i.e. the peak resulting from the boron neutron capture reaction, is Doppler broadened
which means that the multichannel analyzer overestimates the error.
The first step in the calculation of error was to determine the error in the count rates for
each peak in each sample, i.e. the individual errors in Bn, Bo, H,, Ho. This was done using
the error calculation formula for "Multiplication or Division by a Constant" (Knoll, 1989).
The second step was to calculate the error in Bt and Ht, or the net boron and hydrogen
count rates for each sample. This was done by directly applying the formula for the error
in "Sums or Differences of Counts" (Knoll, 1989).
The third and last step was to determine the error in the B/H ratio given knowledge of the
error in both the net boron and hydrogen count rates. This was calculated by applying the
error propagation formula for "Multiplication or Division of Counts" (Knoll, 1989) to this
particular problem, i.e.
A (B/H) 2 ABt 2 + AHt2 (Eq. 3.3)
B/H Bt Ht
This equation can be solved to yield the percent error in the B/H ratio which is the manner
of error expression used in this thesis.
A calibration curve was constructed by plotting B/H ratio of the standards versus their IOB
concentration. The data were linearly fit with the origin of the line forced through (0,0).
The error in the slope and the chi squared value were given as part of the line fit done with
Mackintosh Kaleidagraph.
The next step in the analysis was to determine the IoB concentration for the samples using
the calibration curve. The B/H ratio of each sample was divided by the slope of the cali-
bration curve since the expression of the slope was the increase in B/H ratio over the
increase in concentration.
Again, error was calculated for the concentration by applying standard error propagation
formula to this particular problem (Knoll, 1989), i.e.
AC) 2 = ((A (B/H)) 2 + Am) 2 ) (Eq. 3.4)
where AC is the error in concentration, C is the concentration, Am is the error in the slope
of the calibration curve and m is the slope of the calibration curve.
Since for each set of conditions at least three samples were used, as a last step the average
uptake and percent error were calculated. In addition, the uptake was plotted as a function
of weight when there were three or more sets of samples for a given condition.
3.1.4 Specific experimental conditions
IoB Uptake was measured for freshly excised synovium and cartilage as a function of both
incubation concentration and incubation time. The cartilage was either osteoarthritic
(OA), i.e. from a joint not afflicted by RA, or rheumatoid arthritic (RA), i.e. from a joint
afflicted with RA. These two forms of cartilage are expected to behave similarly. In one
instance bovine cartilage was used as a substitute. Again, similar behavior was expected.
The boron compound used for these studies was K2B12H12 unless otherwise specified. It
was mixed with RPMI cell culture medium consisting of 1% penicillin streptomycin and
10% fetal bovine serum to yield boronated incubation medium of different concentrations,
namely 100 ppm, 500 ppm and 1000 ppm.
Unless otherwise specified, tissue was obtained from an operating room of Brigham &
Women's Hospital, cut into samples and incubated under the experimental conditions
which will be described below. After incubation, the samples were thoroughly rinsed in
saline.
Samples were stored at -70o until Prompt Gamma Neutron Activation Analysis at the MIT
Research Reactor could be performed. Each teflon vial was measured with and without
tissue in order to determine the weight of the tissue. The nine experimental conditions
used will be described below.
(i) Uptake by RA synovium as a function of incubation concentration
RA synovium was incubated for 1 hour with nominal incubation media concentrations of
100, 500 and 1000 ppm '0B. The actual media concentrations were measured during the
Prompt Gamma Neutron Activation Analysis experiment.
(ii) Uptake by RA synovium as a function incubation time
RA synovium was incubated at a nominal concentration of 1000 ppm for varying time
points, namely 15 minutes, 30 minutes and 1 hour. A sample was also incubated in 50 ppm
'lB boric acid solution for 1 hour.
(iii) Uptake by OA cartilage as a function of boron compound
OA cartilage was incubated for 1 hour at a nominal 100 ppm concentration of IoB boric
acid solution (unenriched in IoB) and a nominal 1000 ppm concentration of K2BI2H1 2. The
tissue was also sprinkled with about 10 mg. of boron particulate and incubated for 1 hour.
The boron particulate was 99.9% boron metal, enriched in I'B (94%), with particle sizes
ranging from 5 to 40 gm in diameter and averaging about 15 gim.
(iv) Uptake by RA synovium and cartilage as a function of both incubation concentration
and time
RA synovium was incubated for 1 hour with nominal incubation media concentrations of
100, 500 and 1000 ppm I'B and for 24 hours with a nominal concentration of 1000 ppm.
RA cartilage was incubated for 1 hour with nominal incubation concentrations of 500 and
1000 ppm.
(v) Uptake by RA synovium and cartilage as a function of both incubation concentration
and time
Both RA synovium and cartilage were incubated in nominal concentrations of 100, 500
and 1000 ppm IoB for 1 and 2 hours.
(vi) Uptake by RA cartilage as a function of incubation concentration and time
RA cartilage was incubated in nominal concentrations of 100 and 1000 ppm '0B for 1 and
24 hours.
(vii) Uptake by RA synovium as a function of sample size
RA synovium samples were divided into three categories, small, medium and large, and
incubated at nominal concentration of 1000 ppm for 1 hour.
(viii) Uptake by RA synovium as a function of sample size at a different time point
The same conditions as (vii) were used except that the incubation time was 24 hours.
(ix) Uptake by large pieces of bovine cartilage
A set of 4 samples of large bovine cartilage pieces were incubated for 1 hour at a nominal
concentration of 1000 ppm.
The results of these experiments will be presented section 4.1.
3.2 Thermal Neutron Irradiation
In order to verify cell kill by the 'OB(n,cX) 7Li reaction, tissue previously incubated with the
boron compound was irradiated with thermal neutrons in the thermal neutron beam port of
the MIT Research Reactor. An identical set of samples was set aside, not to be irradiated,
and was placed in incubators. The incubation specifications and dosimetry will be
explained in the following section. After irradiation (or incubation for the same amount of
time for the control samples), the tissue samples were fixed with formalin for histological
analysis.
3.2.1 Incubation and dosimetry for RA synovium irradiation
A set of four samples of RA synovium was incubated for 1 hour at a nominal K2B1 2H1 2
incubation medium concentration of 1000 ppm '0B. After incubation samples were thor-
oughly rinsed in saline and placed into cryovials so that all four samples could fit into the
holder to be used during thermal neutron beam irradiation. About 1 ml of fresh medium
was placed in each cryovial. Two pieces of RA synovium tissue which were not incubated
in IoB were included as controls.
In light of the empirical finding that approximately 10,000 rad must be delivered to the
synovium (Shortkroff et al, 1993), calculations were done in order to determine the time
necessary to deliver 10,000 rad to the RA synovium samples using the 2PH2 port with a
flux of 8x10"1 n/cm2s.
The first step in this calculation was to consider all the possible components of total dose
to the sample, Dt, i.e. the dose due to fast neutrons, Df, and slow neutrons, DI, dose due to
'lB, DBal, and gamma-rays, Dy. The expression is
D t = Df+ Dth + DBIO + D (Eq. 3.5)
where, in turn, Dy, is equal to
ind dir B10D = D + di +DD (Eq. 3.6)
or the dose due to induced gamma-rays, gamma-rays from the beam and gamma-rays from
the boron neutron capture reaction.
These two equations can be simplified by using characteristics of the beam and the size of
the sample. The fast neutron and gamma contamination in the thermal neutron beam at the
2PH2 port is negligible, thereby making the Df and D dir zero. The dose due to the photons
from the core, the induced photons and the photons from the DyBIo, can also be assumed
negligible. Thus, the total dose delivered to the synovium has the following components
Dtot = Dth + DB10 (Eq. 3.7)
(Solares, 1991). The dominant contributions to dose are made by the thermal neutrons and
the dose delivered by the boron neutron capture reaction.
The dose delivered to the tissue by each component is a function of thermal neutron flux,
time of irradiation, the appropriate KERMA values (to convert fluence to dose) and RBE
values. The expression for the dose due to thermal neutrons is
Dth = Oth tir -Kth . RBEth (Eq. 3.8)
where h, is the thermal neutron fluence, tir is the irradiation time, Kth is the thermal neu-
tron KERMA factor and RBEth is the RBE value for thermal neutrons (Solares, 1991).
Similarly, for the dose delivered by the 'OB(n,a)7Li reaction
DBIO = Oth ir -Kth -RBEB10. CBIO (Eq. 3.9)
where t, is the thermal neutron fluence, ti, is the irradiation time, Kth is the thermal neu-
tron KERMA factor, RBEBIo is the RBE value for IoB and CBlo is the '0B concentration
(Solares, 1991).
The above two equations, Eq. 3.8 and Eq. 3.9, can be combined yielding
Dtot =th tir (Kth . RBEth + KBIO . RBEBlo . CBIO) (Eq. 3.10)
which can be solved for tir, resulting in the following expression
Dtot
tir = RBEth + RBE (Eq. 3.11)
r th (Kth -RBEth +K -RBEB10 -CBIo)
The values for the calculation of tir are as follows:
D,,,t = 10,000 cGy
th = 8x10" n/cm2s
Kth = 1.5x10-" cGy/ (n/cm2)
RBEth = 3.2
KBo0 = 8.72x10-' 2 cGy/ (n/cm 2)(ppm)
RBEBlo= 1.35
CBIO = 300 ppm
The RBE values are from Zamenhof et al (Zamenhof et al, 1989) and the KERMA values
are from Caswell et al (Caswell et al, 1982). The boron concentration chosen was conser-
vative, i.e. from the lower part of the uptake range, as will be shown in the next chapter.
Thus, the irradiation time required to deliver 10,000 rad of dose to the synovium was 3.49
seconds using the above parameters. However, for practical limitations, the sample was
irradiated for 5 seconds. The dose delivered was approximately 14,300 rads. At this point
in time it was discovered that the shutter in the reactor takes 8 seconds to open and to
close. The sample holder is lowered manually into the beam and the time the shutter takes
to open and close is a total of 16 seconds. The uncertainty in the exposure of the synovium
sample to the thermal neutrons was 16 seconds due to the water shutter and 2 seconds due
to the manual lowering of the sample, thus totalling 18 seconds. This was larger than the
irradiation time, 5 seconds and, in turn, made the estimate of the error in the dose deliv-
ered on the order of 360%.
3.2.2 Incubation and dosimetry for bovine cartilage irradiation
The same general method was used for a set of samples of bovine cartilage except for a
change in two parameters: total dose delivered to the cartilage, Dtot, was increased and
concentration of I'B likely to be in the tissue, CBIO, was decreased. These alterations were
made so that the irradiation time could be increased to a level which would yield a large
increase in accuracy in the dose delivered (corresponding to a decrease in error) and to
absolutely ensure cell kill.
The sample was irradiated for 175 seconds, with an uncertainty of 18 seconds (16 seconds
due to the shutter and 2 seconds due to manual operation error). The Dtot delivered was
56,160 rad +10% and the CBm was 30 ppm.
3.3 Neutron Induced Alpha Track Autoradiography
The Neutron Induced Alpha Track Autoradiography technique was used in order to obtain
spatial information on the 'lB uptake by RA synovium (Abe et al, 1986). Neutron Induced
Alpha Track Autoradiography is based on the fact that the alpha particles from the boron
neutron capture reaction are recorded in a track-etch detector (Thellier et al, 1991). Pits
visible using an optical microscope are formed in the places where the alpha-particles
have passed through the track-etch detector and created stress point tracks in it. In order to
know the correspondence of the etched tracks to tissue slices, a superimposition of the
etched tracks and stained tissue slices is performed (Amano et al, 1973). In this way, the
spatial distribution of boron compounds can be obtained.
In addition to spatial information, quantitative information could be obtained by counting
the number of tracks in a region of known area and comparing it with numbers obtained
from standard specimens (Liu, 1986). The size of each pit depends on the amount of
energy deposited by the alpha-particles and on the etching techniques that are used, e.g.
time, temperature and etchant (Durani & Bull, 1987).
The track-etch detector chosen was polycarbonate CR 39 plates (allyl diglycol carbonate,
American Acrylics and Plastic. CT). This track etch detector is insensitive to gamma-rays
and beta-particles. However, it is sensitive to protons below 400 keV thus not completely
eliminating the need to distinguish between tracks. CR 39 track etch detectors do have one
advantage over the other type of track etch detector, cellulose nitrate LR 115 type films
(Kodak), in that they do not have any nitrogen which would cause the release of protons as
a result of the 14N(n,p) 14C reaction and thus obscure the alpha particle tracks.
3.3.1 Sample preparation
Frozen samples mounted on a piece of cork were obtained from storage in the -700 freezer.
The sample types will be described in the next section when their composition becomes
relevant for determining experimental method.
First, the cork was removed from the samples and Optical Cutting Temperature (OCT)
compound (Miles, Inc., Diagnostic Division, Elkhart, IN) was added to the sample. After
the OCT froze, a square was cut with the sample in the center and then mounted on a cry-
ostatic microtome (2800 Frigocut Donsanto). For each sample, a tissue slice was cut with
a 5 gm thickness and mounted on polycarbonate CR 39 track etch detectors. The very next
tissue slice was mounted on a glass slide to be stained for histological analysis. This was
done to superimpose the etched tracks and the stained tissue slices in order to examine the
spatial distribution of boron in the samples (Amano et al, 1973).
3.3.2 Neutron Irradiation
The samples were packed in dry ice and brought to the MIT Research Reactor port 2PH2
for neutron irradiation. However, first, the appropriate irradiation parameters had to be
established in order to ensure the visibility of the tracks. Too much exposure would result
in an oversaturation of tracks rendering the background too high to see the tracks left by
the alpha particles. On the other hand, the power and or time had to be large enough to
induce sufficient boron neutron capture reactions in the first place.
The irradiation parameters were determined using the following guideline for resolution:
15 minute irradiation of a 30 ppm sample at 100 kW (Solares, 1995). The time, sample
concentration and reactor power all scale linearly.
Due to the significant time involved in manually lowering and raising the sample holder
and in order to reduce the resulting experimental error, it was decided that the time should
remain constant at 15 minutes and the reactor power would be adjusted. This implied that
the samples had to be classified as "high" and "low" expected concentrations as based on
previous results in order to scale the required reactor power accordingly. For example, the
reactor power for the tissue incubated with the particulate or K2B12H12 had to be a factor of
ten lower than for the tissue incubated with boric acid.
Table 3.2 summarizes the type of sample used and the power required for each one, with
the irradiation time fixed at 15 minutes. In the table below, surface refers to a slice that
was taken from the surface of the tissue whereas inner refers to a slice taken 1 mm into the
tissue.
Table 3.2: Autoradiography sample irradiation parameters
Sample Power (kw)
10B particulate: surface 3.3
10B particulate: inner 3.3
K2B12H12: 15 min. 3.3
K2B 12H12: 30 min. 3.3
Boric Acid: 1 hour 33
Standard: 11.63 ppm 33
Control: tissue in medium 33
3.3.3 Etching
A 6.5 N NaOH solution was made by dissolving 77.8 grams of solid NaOH (Molecular
Weight of 40.00, lot 28F-0852, No. S-5881 Sigma Chemical Company, St. Louis, MO) in
300 ml of H20. This concentration was used because it has been empirically determined
that at this concentration of NaOH, tracks can be etched by soaking the CR 39 slides for
18 minutes in a 700 water bath (Solares, 1995). There are two factors affecting the rate at
etching (Durani & Bull, 1987). The first is the temperature at which the etching takes
place, i.e. the lower the temperature, the longer the time to etch. The other is the NaOH
concentration, i.e. the lower the concentration, the longer the time to etch.
3.3.4 Staining
The tissue slices mounted on the glass slides were stained with hematoxylin-eosin stain
according to the following protocol. First the slides were left in hematoxylin for 5 minutes
and then rinsed in deionized water. Afterwards they were dipped in sodium borate solution
(which was made by dissolving 64g of sodium borate powder, Na2B40 7-10H 20, in 100ml
deionized water) and rinsed again in deionized water.
The next step in the procedure involved leaving the slides in Eosin for 5 minutes. The
slides were soaked in 95% EtOH for 2 minutes and in 100% EtOH for 6 minutes. Finally,
the slides were soaked in xylene for 4 minutes. Cover plates were mounted on the slides.
3.3.5 Analysis
The intended analysis was through the use of the superposition technique whose spatial
resolution has been determined to be on the order of tm (Lui, 1989). In this technique
micrographs of the etched detectors and glass stained slides are obtained and scanned into
a computer. The digitized images are then superimposed to reveal the spatial distribution
of IoB in the samples. However, before embarking on this lengthy procedure, the etched
detectors were carefully observed under a microscope.
This chapter has described the methods used in the in vitro analysis of ' 0B uptake, namely
Prompt Gamma Neutron Activation Analysis, Thermal Neutron Irradiation and Neutron
Induced Alpha Track Autoradiography. Results of these experiments will be presented in
the following chapter.
4 In Vitro Analysis of 10B Uptake: Results
Complete results of the in vitro analysis of I'B uptake will be presented in this chapter in
the same order as the methods were described in the previous chapter, i.e. starting from the
results of Prompt Gamma Neutron Activation Analysis, Thermal Neutron Irradiation and
ending with Neutron Induced Alpha Track Autoradiography.
4.1 Prompt Gamma Neutron Activation Analysis
Results will be presented in the same order that the experimental conditions were pre-
sented in Section 3.1.3. Unless otherwise specified, the boron compound used was
K2B 2H12. Before presenting the experimental results, it must be emphasized again that the
boron compound was not enriched in '0B. Since natural boron has only 20% '0B, all the
concentrations obtained could be increased by a factor of five if boron 100% enriched in
lOB were used.
(i) Uptake by RA synovium as a function of incubation concentration
RA synovium bulk uptake as a function of incubation concentration is shown in Table 4.1.
Table 4.1: Uptake by RA synovium as a function of incubation concentration
Incubation Weight Uptake Error Ave. Uptake Ave. Error
(g) (ppm) (%) (ppm) (%)
100 ppm 0.13 41.1 10.7 39 14
0.10 45.2 14.9
0.14 31.5 16.6
500 ppm 0.18 513.4 9.4 322 9
0.18 227.9 8.8
0.13 224.8 9.5
1000 ppm 0.20 539.2 8.7 497 10
0.18 406.2 9.0
0.15 545.3 10.7
Control 0.08 0 0 0 0
For this experiment, the concentrations of the media were measured. The nominal 100
ppm solution was actually measured to contain 110 ppm, the 500 ppm solution 570 ppm
and the 1000 ppm solution 1050 ppm. This shows that there is good agreement between
the intended concentration and the actual one. In general, they are within 10% of each
other. This is important because the concentrations of the media were not measured in all
experiments.
As can be seen from Table 4.1, average I'B concentrations achievable in RA synovium
range from approximately 40 ppm to 500 ppm with the incubation medium concentration
ranging from 100 ppm to 1000 ppm. The uptake by RA synovium does not increase in a
linear fashion. The data do not immediately suggest a saturation mechanism in that the
average concentration achieved with a 1000 ppm incubation, 497 ppm, should be lower if
a saturation mechanism were in effect. However, this does not exclude that the uptake
could be approaching saturation, a process which could be affected differences in tissue.
(ii) Uptake by RA synovium as a function of incubation time
Uptake by RA synovium as a function of incubation time is shown in Table 4.2(a). The
incubation concentratioi was constant at a measured concentration of 1146±7.5%ppm.
Table 4.2 (a): Uptake by RA synovium as a function of incubation time
Incubation Weight Uptake Error Ave. Uptake Ave. Error
Time (g) (ppm) (%) (ppm) (%)
15 min. 0.24 189.6 8.8 197 9
0.26 239.1 8.2
0.14 161.7 10.3
30 min. 0.20 297.7 8.3 297 8
0.21 312.0 7.1
0.12 282.5 9.1
1 hr. 0.18 474.5 9.3 381 9
0.11 344.4 10.0
0.25 324.9 8.4
Table 4.2 (a): Uptake by RA synovium as a function of incubation time
Incubation Weight Uptake Error Ave. Uptake Ave. Error
Time (g) (ppm) (%) (ppm) (%)
control 0.09 0 0 0 0
These results indicate that the rate of uptake is not constant. The fastest rate of uptake
occurs in the first fifteen minutes with one half to one third of the uptake taking place. For
an increase in time by a factor of 4 (from 15 minutes to 1 hour), the concentration less than
doubled, going from an average of 197 ppm to an average of 381 ppm.
In addition, a set of samples was incubated in a boric acid (BA) solution measured to be
50 ppm ±7.8% and the results are presented in Table 4.2(b). The average uptake was 15
ppm, less than half the concentration in the medium. This uptake is consistent with the
uptake reported in preliminary work with boric acid which showed that about 40 ppm was
taken up after incubation for 1 hour at a nominal incubation concentration of 90 ppm of
unenriched boric acid (Johnson et al, 1994).
Table 4.2 (b): Uptake of Boric Acid by RA synovium
Incubation Weight Uptake Error Ave. Uptake Ave. Error
(g) (ppm) (%) (ppm) (%)
BA: 1 hr 0.14 16.7 9.2 15 17
0.13 10.3 31.0
0.18 17.4 11.4
It must be noted that there are no controls included in Table 4.2(b) because this experiment
was done at the same time as the experiment whose results are presented in Table 4.2(a)
and only one control was done for the whole experiment.
(iii) Uptake by OA cartilage as a function of boron compound type
The uptake in OA cartilage as a function of boron compound was measured using the
three different compounds described in section 3.1.4. In Table 4.3, which presents the
results of this experiment, the following notation will be used. The boron particulate will
be denoted by BP. The unenriched boric acid solution at the nominal concentration of 100
ppm will be denoted as BA and the boron compound, K2B12H1 2, unenriched in IoB at a
nominal concentration of 1000 ppm, will be noted by KBH. The incubation time for all
compounds was constant at 1 hour. The concentrations of the media were not measured.
However, as can be seen from the experimental results presented in (i) of this section, the
media should equal the nominal concentrations to within 10%.
Table 4.3: Uptake of OA cartilage as a function of boron compound
Incubation Weight Uptake Error Ave. Uptake Ave. Error
(g) (ppm) (%) (ppm) (%)
BP 0.02 39.1 7.0 56 7
0.01 24.5 7.2
0.01 68.9 6.9
0.04 92.0 6.9
BA 0.07 4.84 8.4 2.6 12
0.02 --- ---
0.03 0.45 14.7
0.02 --- ---
KBH 0.03 31.2 7.1 30 7
0.01 29.9 7.3
0.05 35.6 7.1
0.02 24.3 7.6
Control 0.02 0 0 0 0
Those entries marked with (---) correspond to samples for which no reasonable result
could be obtained, i.e. the concentration was negative. Possible reasons for this include the
weight of the sample relative to the error in the vial weight. This will be discussed in detail
in the final chapter of this thesis. Table 4.3 shows that the highest uptake of OA cartilage is
with the boron particulate averaging 56 ppm. The lowest is the boric acid solution which
averages 2.6 ppm. The uptake of K2B12H12, averaging 30 ppm, is comparable to the frac-
tion uptake of the boric acid solution.
(iv) Uptake by RA synovium and RA cartilage as a function of incubation concentration
and incubation time
The results of this set of experimental conditions, as described in 3.1.4, are shown in the
following table, Table 4.4.
Table 4.4: Uptake by RA synovium and RA cartilage as a function of
and incubation time
concentration
Incubation Weight Uptake Error Ave.Uptake Ave. Error(g) (ppm) (%) (ppm) (%)
sy: 100 ppm:1 hr 0.60 16.8 8.7 19 9
0.35 18.7 9.0
0.93 22.1 8.6
0.57 16.6 8.8
sy:500 ppm: 1 hr 0.54 63.4 8.5 79 8
0.40 105.2 8.1
0.36 82.1 8.4
0.47 64.4 8.2
sy:1000 ppm:1 hr 0.62 124.9 8.1 190 8
0.80 145.2 7.4
0.64 217.5 7.8
0.30 270.8 8.0
sy: 1000 ppm:2 hr 0.45 190.8 8.1 198 10
0.41 250.2 7.4
0.73 158.9 7.8
0.50 191.7 8.0
sy: 1000 ppm:24 hr 0.37 49.6 6.9 44 7
0.56 35.9 6.9
0.50 45.5 6.8
0.62 44.4 6.8
sy: controls 0.61 0 0 0 0
Table 4.4: Uptake by RA synovium and RA cartilage
and incubation time
as a function of concentration
Incubation Weight Uptake Error Ave. Uptake Ave. Error
(g) (ppm) (%) (ppm) (%)
1.00 0 0
0.77 0 0
0.44 0 0
ct:500 ppm:1 hr 0.04 45.1 7.0 30 8
0.02 15.3 9.1
0.03 30.5 7.5
ct: 1000 ppm: 1 hr 0.07 84.9 6.9 107 7
0.05 128.6 6.9
ct: controls 0.03 0 0 0 0
0.05 0 0
0.03 0 0
The average concentrations achieved in the synovium samples at the same incubation
solutions and times are significantly lower than those presented in Table 4.1, i.e. the aver-
age concentration for a 1 hour 100 ppm incubation was 19 ppm, for 500 ppm was 79 ppm
and for 1000 ppm was 190 ppm compared to the averages 39 ppm, 322 ppm and 497 ppm,
respectively, from Table 4.1.
The weights of the samples in this experiment, however, were higher than the weights in
experiment (i). The ranges for the 1 hour incubations at nominal concentrations of 100,
500 and 1000 ppm were 0.35-0.93g, 0.36-0.54g, 0.30-0.64g in this experiment while in
experiment (i) the ranges were 0.10-0.14g, 0.13-0.18g and 0.15-0.20g, respectively. The
dependence of measured uptake on sample size will be specifically tested in experimental
conditions (viii) and (ix).
The synovium samples incubated for 24 hours in the 1000 ppm seem to be inconsistent
with the rest of the experiment; their average uptake was 44 ppm while the average uptake
of the samples incubated for 1 hour was 107 ppm. The average uptake for 24 hour should
have been greater than for 1 hour if the uptake were to keep increasing with time.
The uptake of cartilage when incubated in a 500 ppm solution for 1 hour was less than half
of the uptake of synovium. The magnitude of this differential was not maintained when
samples were incubated in a 1000 ppm solution. The average cartilage uptake increased to
107 ppm, more than half of the synovium uptake at that concentration, 190 ppm.
(v) Uptake by RA synovium and RA cartilage as a function of incubation concentration
and time
Results of this experiment are presented in Table 4.5. Essentially, the same type of experi-
ment was performed as (iv) except that the comparison is more complete. The nominal
incubation medium concentration for 100 ppm corresponded to a measured value of
97±7.6% ppm, for 500 ppm to 490+7.2% and then for 1000 ppm to 1025±7.5%. Again, the
measured concentrations are within 10%. In the table, the nominal concentrations are
listed rather than the measured ones.
Table 4.5: Uptake by RA synovium and cartilage as a function of incubation
concentration and incubation time
Incubation Weight Uptake Error Ave. Uptake Ave. Error
(g) (ppm) (%) (ppm) (%)
sy: 100 ppm: 1hr 0.23 33.2 7.1 42 7
0.23 46.1 7.1
0.20 42.2 7.0
0.25 44.7 7.1
sy: 100 ppm:2 hr 0.37 49.8 8.8 57 9
0.33 48.4 8.5
0.20 70.4 8.9
0.36 58.7 9.0
sy:500 ppm: 1 hr 0.24 185.5 8.1 166 8
Table 4.5: Uptake by RA synovium and cartilage as a function of incubation
concentration and incubation time
Incubation Weight Uptake Error Ave. Uptake Ave. Error
(g) (p) pm (%) (ppm) (%)
0.43 150.4 7.6
0.37 203.8 7.8
0.37 126.0 7.6
sy:500 ppm:2 hr 0.40 189.5 7.4 241 7
0.42 227.1 7.3
0.28 269.5 7.7
0.27 277.6 7.4
sy: 1000 ppm: 1 hr 0.26 228.5 7.8 289 7
0.25 314.3 7.5
0.27 280.2 7.6
0.26 331.1 7.6
sy:1000 ppm: 2 hr 0.35 468.3 7.4 428 7
0.25 473.2 7.9
0.32 369.7 7.3
0.41 401.3 7.3
sy: control 0.43 0 0 0 0
0.41 0 0
0.28 0 0
0.28 0 0
ct: 100 ppm: 1 hr 0.02 54.6 8.2 58 8
0.04 87.3 7.9
0.02 34.4 7.4
ct: 100 ppm: 2 hr 0.03 ---- ---- ---- ----
0.06 ---- ----
0.03 ---- ----
ct: 500 ppm: 1 hr 0.02 ---- --- 186 9
Table 4.5: Uptake by RA synovium and cartilage as a function of incubation
concentration and incubation time
Incubation Weight Uptake Error Ave. Uptake Ave. Error
(g) (ppm) (%) (ppm) (%)
0.02 --- ---
0.02 186 9
ct: 500 ppm: 2 hr 0.03 ----- ---- ---- ----
0.02 ---- ----
0.03 ---- ----
ct: 1000 ppm: 1 hr 0.01 ---- ---- ---- ----
0.03 ---- ----
0.01 ---- ----
ct: 1000 ppm: 2 hr 0.01 ---- ---- ---- ----
0.04 ---- ----
0.03 ---- ----
ct: control 0.03 0 0 0 0
0.01 0 0
0.01 0 0
The average uptake of the synovium at the incubation time of 1 hour and concentration of
100 ppm was 42 ppm, comparable to the 39 ppm of experiment (i). As indicated in the
above table, the average synovium uptake at the incubation concentrations of 500 ppm
and 1000 ppm were 166 ppm and 289 ppm, lower than the uptake at the corresponding
concentrations in experiment (i), i.e. 322 ppm and 497 ppm. It must be noted that the aver-
age weights of the samples was greater in this experiment than in experiment (i).
Within this experiment, the two hour incubation caused increased uptake which as before
was not linear with increased incubation time. However, this time, the concentration did
not overestimate a linear increase, i.e. the uptake more than doubled with the doubling of
the time, but rather underestimated it, i.e. the uptake was less than double with the dou-
bling of time. This suggests the beginning of a saturation point in the uptake.
The cartilage samples in this experiment did not give satisfactory results. The few results
which were obtained did not indicate a differential with synovium uptake, i.e. the uptakes
of cartilage and synovium were comparable.
(vi) Uptake by RA cartilage as a function of incubation concentration and time
Results for examples at this set of experimental parameters is shown in Table 4.6.
Table 4.6: Uptake by RA cartilage as a function of incubation concentration and time
Incubation Weight Uptake Error Ave. Uptake Ave. Error
(g) (ppm) (%) (ppm) (ppm)
100 ppm: 1 hr 0.01 3.45 15.6 4 14
0.03 4.99 12.9
0.05 3.78 14.7
100 ppm:24 hr 0.01 1.32 23.0 2 12
0.03 2.37 17.4
0.03 3.31 15.6
1000 ppm: 1 hr 0.04 17.8 7.62 42 7
0.04 60.6 6.93
0.02 47.6 7.05
1000 ppm:24 hr 0.01 29.9 7.48 28 7
0.04 25.2 7.48
0.04 --- ---
controls 0.01 0 0 0 0
0.01 0 0
0.02 0 0
As can be seen in the Table 4.6, the uptake of cartilage is an average of 4 ppm as a result of
incubation with a nominal solution concentration of 100 ppm and an average of 42 ppm
for incubation with a nominal solution concentration of 1000 ppm. The increase in uptake
as a function of incubation concentration appears to be linear. This uptake is about ten
times less than the uptake observed in synovium which is on the order of 40 ppm for incu-
bation with 100 ppm and on the order of 400 for incubation with 1000 ppm. This would
mean that there is a differential of 10:1 between synovium and cartilage uptake.
However, the data suggest that after a point uptake may be inversely proportional to the
incubation time. The average uptake for incubation with a nominal concentration of 100
ppm is halved when the average uptake for incubation with a nominal concentration of
1000 ppm decreases by one quarter. From these two observations, it can be said at 24
hours the average uptake decreases with increasing incubation concentrations.
(vii) Uptake by RA synovium as a function of sample size
For this experiment, the nominal incubation concentration was set at 1000 ppm and the
time of incubation set to 1 hour. Results of the uptake as a function of sample size are
shown in Table 4.7.
Table 4.7: Uptake by RA synovium as a function of sample size
Size Weight Uptake Error(%) Ave. Uptake Ave. Error
(g) (ppm) (ppm) (%)
large 0.26 228.5 7.8 289 8
0.25 314.3 7.5
0.27 280.2 7.6
0.26 331.1 7.6
control 0.24 0 0 0 0
0.23 0 0
medium 0.21 321.7 8.4 320 8
0.16 332.4 8.7
0.20 275.4 8.4
0.17 350.9 8.2
control 0.09 0 0 0 0
0.06 0 0
Table 4.7: Uptake by RA synovium as a function of sample size
Size Weight Uptake (%) Ave. Uptake Ave. Error
(g) (ppm) (ppm) (%)
small 0.08 340.4 9.6 344 9
0.09 300.4 9.1
0.08 355.7 9.8
0.10 380.3 9.2
control 0.03 0 0 0 0
0.03 0 0
The difference in average uptake between the "large" and "medium" pieces is not very
large. In fact, taking into account the magnitude of the errors, there is overlap between the
ranges. For example, taking the higher possible value for the average uptake of the large
pieces, i.e. 289 + 8% of 289 ppm, yields 312 ppm. This is higher than taking the lowest
value for the medium size uptake, i.e. 320 - 8% of 320 ppm which yields 294 ppm. The
average weight of the large pieces is 0.26 g while of the medium pieces of 0.19 g and of
the small pieces of 0.09 g with no overlapping sizes.
(viii) Uptake by RA synovium as a function of sample size at a different time point
This experiment is essentially the same as (vii) except that time of incubation was
increased to 24 hours. Results are shown in Table 4.8 below.
Table 4.8: Uptake by RA synovium as a function of sample size at a different time
point
Size Weight Uptake Error Ave. Uptake Ave. Error
(g) (ppm) (%) (ppm) (%)
large 0.18 410.6 7.2 426 8
0.18 458.3 8.7
0.19 417.1 8.7
0.20 419.2 8.6
control 0.11 0 0 0 0
0.12 0 0
Table 4.8: Uptake by RA synovium as a function
point
of sample size at a different time
Size Weight Uptake Error Ave. Uptake Ave. Error
(g) (ppm) (%) (ppm) (%)
medium 0.05 462.6 8.2 526 9
0.07 551.4 8.8
0.09 551.5 8.7
0.08 537.8 8.9
control 0.04 0 0 0 0
0.07 0 0
small 0.03 1144.2 8.6 1080 10
0.04 1252.4 10.9
0.03 1069.0 10.4
0.02 854.0 10.9
control 0.04 0 0 0 0
0.04 0 0
The difference between average sample uptake of the three different sizes is significant. In
other words, taking the highest possible value in the average uptake of the large samples
(426 + 0.08*426) yields 460 ppm which is lower than 573 ppm, the lowest value using the
averages and errors for the medium samples listed above (526+0.09*526). The average
weights in this experiment were, 0.19 g for the large pieces, 0.75 g for the medium pieces
and 0.03 g for the small ones.
(ix) Uptake by large pieces of bovine cartilage
Bulk tissue uptake was measured for large pieces of bovine cartilage and Table 4.9, below,
shows the results.
Table 4.9: Uptake by large pieces of bovine cartilage
Size Weight Uptake Error Ave. Uptake Ave. Error
(g) (ppm) (%) (ppm) (%)
large 0.36 436.4 7.2 617 8.7
Table 4.9: Uptake by large pieces of bovine cartilage
Size Weight Uptake Error Ave. Uptake Ave. Error
(g) (ppm) (%) (ppm) (%)
0.11 644.1 8.7
0.13 803.1 8.7
0.21 585.2 10.2
control 0.22 0 0 0 0
0.18 0 0
0.21 0 0
0.13 0 0
In this set of samples the uptake by cartilage was large, an average of 617 ppm comparable
to synovium. This is in direct conflict with other experimental data presented previously.
In an attempt to understand the relationship between uptake and sample size, a plot was
made of uptake versus sample size, using only those experiments with three or more sets
of samples. All the data in the previous tables were combined and shown in Figure 4.1.
Average Sample Uptake vs. Sample Weight
3 ----- --
h 0 -  O ---z 7 . . ... "- -
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-0- 100 ppm 1 hour
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-A- 1000 ppm: 1 hour
-0- 1000 ppm: 24 hour
Figure 4.1 Average Sample Uptake vs. Weight for sets with three or more experiments.
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As seen in Figure 4.1, the uptake for the 24 hour incubation at a nominal concentration of
1000 ppm yielded uptake that was greater than 1000 ppm. For the 1 hour incubation at
1000 ppm, the decrease in uptake versus sample size is not smooth but shows an increase
around 0.2 g. The average uptake for the samples incubated for 1 hour at 100 ppm
remained relatively constant as the weight of the sample changed.
A possible explanation for Figure 4.1 could be related to a limited diffusion distance of the
boron compound inside the tissue. When boron uptake is determined via Prompt Gamma
Neutron Activation Analysis, the B/H ratio is used in order to correct the effects of
improper sample positioning in the beam and reduce variations in thermal neutron flux.
However, if the boron compound were only able to diffuse a certain distance into the tis-
sue and the sample size were big, then the ratio which is inversely proportional to the size
of the tissue, or the hydrogen content would decrease.
4.2 Thermal Neutron Irradiation
In light of the unacceptably large error in the dose delivered to the RA synovium samples,
those results are not hereby included. The results of the thermal neutron irradiation of the
cartilage samples were equivocal. There did not appear to be any difference between the
boronated and nonboronated irradiated cells, or between the irradiated and nonirradiated
sets of samples. A wash out of proteoglycans was observed in all samples, suggesting that
the wash out could be due to in vitro cell culture rather than irradiation. In fact, a problem
with in vitro work is that tissue is slowly undergoing autolysis, i.e. breaking down, making
it difficult to attribute cell kill to irradiation rather than normal autolysis.
Results of this experiment with RA cartilage are shown in the following figures. More
specifically, Figure 4.2 shows the results of thermal neutron irradiation of both boronated
and nonboronated cells. Figure 4.3 shows the control set of samples, i.e. the boronated and
nonboronated samples that were placed in incubators rather than irradiated. In all pictures,
the washout of the proteoglycans is indicated by gradual discoloring towards the bottom
of each picture.
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Figure 4.2 Results of thermal neutron irradiation on (a) boronated
and (b) nonboronated samples of osteoarthritic cartilagce
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4.3 Neutron Induced Alpha Track Autoradiography
Of all the track etch detectors used and samples tried, only one of the sample which had
been incubated in a boron particulate gave an indication of alpha particle tracks. However,
the corresponding section of tissue was not available and hence the superimposition of the
track etch detector with the glass slide could not be done to yield significant information
on the boron distribution. The rest of the slides showed either undersaturation, i.e. the
boron neutron capture reaction was not induced, or oversaturation, i.e. the track etch
detector was exposed for too long and the background from the protons was so strong that
it overpowered the alpha particle tracks. During the experiment, a problem occurred with
the shutter of the reactor and the reactor power was only known with an uncertainty of
approximately 50%. Since Neutron Induced Alpha Track Autoradiography is sensitive to
reactor power, this uncertainty caused the lack of useful results.
5 Neutron Beam Design: Methods
This chapter will present the method used to design an accelerator-based neutron beam for
BNCS. The first step in the design was to determine the neutron beam energy range
required for BNCS. This was done by studying the dosimetric properties of "ideal",
monoenergetic, photon-free neutron beams ranging in energy from 0.025 eV to 10 keV in
a phantom model of a knee. Both monodirectional and isotropic ideal neutron beams were
studied representing the two extremes of angular distribution of neutrons emerging from a
moderator/reflector assembly. The methodology used will be described in section 5.1
Having determined the therapeutically useful neutron energy range for BNCS, attention
was then turned to the design of a moderator/reflector assembly which would be able to
moderate the energetic neutrons coming from the accelerator source to the therapeutically
useful neutron energy range determined in the first step. In order to evaluate the assembly
in air rather than in a phantom, thereby reducing the computation time required, a Figure
of Merit was formulated and tested by comparison of the results with those obtained in a
phantom, as discussed in section 5.2.
The next step was to evaluate which of two neutron producing reactions, 7Li(p,n)7Be or
9Be(p,n) 9Be, would be most appropriate for BNCS. The material, such as lithium and
beryllium, which when irradiated with protons produces neutrons is referred to as target
material. The process of target selection will be discussed in section 5.3.
Finally, materials for the moderator/reflector assembly were selected. This selection was
done by modifying work done by Yanch et al for an accelerator based epithermal neutron
beam design for BNCT (Yanch et al, 1992) to fit the requirements of BNCS. The dose and
flux dependence on both the length and diameter of both the moderator and reflector was
investigated. This part of the neutron beam design process will be described in section 5.4.
The computational method used for the entire beam design was Monte Carlo for Neutron
and Photon Transport Code (MCNP) version 4A (Breismeister, 1986) which is installed
on Sun Sparc Stations at the Whitaker College Biomedical Imaging and Computational
Laboratory at MIT. Advantages of this code which has been used extensively for many
years include the use of point-wise continuous energy cross-section data from a number of
sources, complete three-dimensional freedom in designing any configuration of materials
and a sophisticated built-in geometry package to aid in debugging.
5.1 Determination of Optimal Neutron Energy Range
5.1.1 Monodirectional Ideal Beams
The geometry used for the monodirectional ideal beam studies is shown in Figure 5.1. The
phantom model consists of a series of concentric cylinders representing the different tissue
layers found in the arthritic joint. The knee was chosen as the model because it is the joint
on which synovectomy is most commonly performed (Fleming et al, 1976). The tissue
thicknesses of the knee phantom were obtained from Magnetic Resonance Images of
human arthritic knees. A 10 cm diameter monoenergetic neutron beam was placed 1.65
cm away from the phantom surface. Absorbed doses were tallied in a cross-section of a
cylinder, with width of 2.5 cm, as shown in Figure 5.1, and height of 6 cm, in the plane
perpendicular to the beam.
- (1.0 cm)
5ynovium (0.3 cm)
novium (0.15 cm)
luid sp. (0.2 cm)
art. cart. (0.2 cm)
bone (5.0 cm)
2.5 cm
(a)
1.65 cm 8.7 cm
Figure 5.1 Ideal beam study geometry of cylindrical joint phantom
using a monodirectional source of neutrons.
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Several assumptions were made in the calculation of dose per depth in the joint phantom.
The first one was that the synovium contained 400 ppm of '0B, a conservative estimate of
the concentrations readily achieved in vitro as seen in chapter 4. The second assumption
was that 3.6x1012 n/s were being emitted from the source. This number was derived from
the total neutron yield expected from the 7Li(p,n)7Be reaction using a proton current of 4
mA, the maximum current expected from the tandem electrostatic accelerator constructed
by Newton Scientific Inc., for the MIT Laboratory for Accelerator Beam Applications
(LABA). Lastly, no RBE values were applied to the calculation of dose.
Fifteen beam energies were simulated ranging from 0.025 eV to 10 keV. Particle flux was
determined as a function of depth for all components: thermal neutrons (neutrons with a
cutoff energy of 0.36 eV), nonthermal neutrons (neutrons with energies above 0.36 eV)
and induced photons, including the 478 keV prompt photon emitted in the 'oB(n,oa) 7Li
reaction. In order to obtain dose rates, both the neutron and photon fluxes were modified
by the fluence-to-kerma conversion factors of Caswell et al (Caswell et al, 1982) and
Zamenhof et al (Zamenhof et al, 1975).
To estimate the 'OB(n,a) 7Li contribution to dose in the synovial lining, the thermal neutron
flux was modified by the 10B fluence-to-kerma conversion factors provided by Zamenhof
et. al (Zamenhof et al, 1975) and multiplied by 400. A similar procedure was followed for
the boron dose contribution to healthy tissue which was assumed to contain 1 ppm of '0B.
Individual dose components were plotted as a function of depth in the joint model for each
energy. Figure 5.2 shows the dose components for beams of energy 0.025 eV and 0.1 eV,
both thermal, according to our definition. Note that two peaks appear in the plots as a
result of calculating synovial dose at both the "front" and "back" of the knee model. For
the 0.025 eV beam, the percent of the gamma dose increases from about 44% of the total
dose at the surface of the phantom to 78% at the midpoint of the bone with the exception
of the synovial lining where the gamma contribution is less than 1% and the boron contri-
bution is approximately 98% of the total dose. The neutron dose decreases from 35% at
the surface of the phantom to approximately 13% at the midpoint of the phantom. As is
clearly seen in Figure 5.2, the boron dose contribution in non-target tissue is the lowest.
The fractional dose contributions for the 0.1 eV are very similar to the 0.025 eV except
that the gamma dose contribution is slightly greater at the surface of the phantom than the
0.025 eV case. The neutron and boron dose contributions, except at the synovium of
course, are slightly lower than the 0.025eV case.
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Figure 5.2 Dose per depth in phantom for ideal monodirectional
beams energies of (a) 0.025 eV and (b) 0.1 eV.
In the next group of beam energies, i.e. 1 eV, 5 eV and 10 eV, shown in Figure 5.3, the
neutron beam energy is increased over the threshold delineating thermal and nonthermal
neutrons and thus there is the appearance of the nonthermal neutron component to dose. It
is interesting to note that in the 1 eV beam, the fractional gamma dose contribution at the
phantom surface is 61% of the total dose, higher than the contribution see from lower
energies even though there is the addition of the nonthermal component to dose. It is also
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interesting to note that the fractional gamma dose increases to approximately the same
value at the midpoint of the bone as the lower energies. For all three beam energies shown
in Figure 5.3, the fast neutron dose is comparable to the thermal and boron doses ranging
from about 10% to 15%. The gamma dose typically ranges from composing 60% of the
total dose at the phantom surface to approximately 80% of the dose at the midpoint of the
bone.
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Figure 5.3 Dose per depth in phantom for ideal monodirectional
beams energies of (a) 1 eV, (b) 5 eV and (c) 10 eV.
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In the next set of three energies, shown in Figure 5.4, the nonthermal neutron dose compo-
nent rises, reaching the thermal component at 25 eV, coming closer at 50 eV until at 75 eV
the fraction of dose due to the nonthermal neutrons is higher than that due to the thermal
neutrons at the skin (though still lower than the gamma dose) and equivalent to both the
boron and the thermal doses by 75 eV. The gamma dose remains relatively constant
throughout these three dose profiles.
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Figure 5.4 Dose per depth in phantom for ideal monodirectional
beams energies of (a) 25 eV, (b) 50 eV and (c) 75 eV.
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Between the next two energies tested and shown in Figure 5.5, the nonthermal neutron
dose increases such that it is comparable to the gamma dose at 125 eV and begins to be
higher than the thermal and boron doses. This hasn't affected the percent contribution of
the boron to the synovium which is still around 98%.
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Figure 5.5 Dose per depth in phantom for ideal monodirectional
beams energies of (a) 100 eV and (b) 125 eV.
By 250 eV, as shown in Figure 5.6, the fast neutron dose is exactly equal to the gamma
dose, both contributing about 45% to the total dose. The boron and thermal contributions
for the 250 eV beam are about 5% each. The fast neutron dose remains consistently higher
than both the thermal and nonthermal for the entire phantom depth. In fact by 500 eV, the
nonthermal neutron dose to the skin is higher than the gamma dose, and the nonthermal
neutron dose is approaching the gamma dose though it is still less. Finally, by 750 eV the
nonthermal dose not only surpasses the gamma dose at the surface but is approximately
equal to the gamma dose until a depth of about 6 cm. At this energy, the fraction of gamma
dose to total dose at the surface of the skin is 20% while the nonthermal dose contribution
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is greater by a factor of three, in fact, around 76%. The boron contribution, except at the
synovium where it is around 97%, remains less than 7% throughout the entire depth of the
phantom. The dose contribution of thermal neutrons ranges from 2% at the surface of the
phantom to 6% at the midpoint of the bone. The features described in the above para-
graphs can be seen in Figure 5.6 below.
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Figure 5.6 Dose per depth in phantom for ideal monodirectional
beams energies of (a) 250 eV, (b) 500 eV and (c) 750 eV.
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The most striking increase in nonthermal neutron dose is seen in the 10 keV beam, Figure
5.7(b). At 10 keV the nonthermal neutron dose is comparable to the boron dose at the syn-
ovium which, as been pointed out before, was around 98%. In fact, the nonthermal neu-
tron dose at the surface of the phantom in the 10 keV was calculated to be 98% of the total
dose, with the other components contributing negligible amounts of dose. The nonthermal
neutron dose has far outstripped the other dose components throughout the joint phantom.
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Figure 5.7 Dose per depth in phantom for ideal monodirectional
beams energies of (a) 1 keV and (b) 10 keV.
5.1.2 Isotropic Ideal Beams
The study conducted in section 5.1.1 was repeated using isotropic ideal beams rather than
monodirectional. This was done to approximate the angular characteristics of the beam
following moderation with a large mass of low-Z material. The results will be divided into
the same sets as the monodirectional studies and comparisons will be made between the
two where possible.
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The geometry for the study is shown in Figure 5.8 and is essentially the same as that used
in the monodirectional studies except for the angular distribution of neutrons emitted from
the source. The calculation of dose per depth in the joint phantom is also the same as in the
monodirectional studies.
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Figure 5.8 Ideal beam study geometry of cylindrical joint phantom
using an isotropic source of neutrons.
Figure 5.9, on the following page, shows the dose per depth profiles in a phantom for the
beam energies of 0.025 eV and 0.1 eV, both of which are considered thermal according to
the previous definition. One immediate difference between the isotropic and monodirec-
tional studies is the difference in dose rate. In the isotropic studies, the dose rate for all
components of the 0.025 eV isotropic beam are around 1x10 -3 rad/s whereas in the mono-
directional study the dose rate was approximately three orders of magnitude higher. The
percent contribution at the surface is about 50% for the gamma rays, 30% for the neutrons
(only thermal exist in this beam) and 20% for the boron. Halfway into the phantom, in the
middle of the bone, these ratios change to 85% for the gammas, 10% for the neutrons and
5% for the boron. The gamma dose rate remains relatively constant throughout the depth
of the phantom while the thermal neutron and boron dose contributions decrease. The 0.1
eV beam has similar dose fraction contributions. Again, as before, the dose at the two
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peaks, representing the front and the back synovium layer, is primarily due to boron., i.e.
approximately 98%.
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Figure 5.9 Dose per depth in phantom for ideal isotropic
beams energies of (a) 0.025 eV and (b) 0.1 eV.
Similarly to the monodirectional beams, as neutron energy increases above the 0.36 eV
threshold a nonthermal component to the dose appears, as seen in Figure 5.10 below.
Although the nonthermal component is stronger than both the thermal neutron and boron
dose components at the surface of the skin, it is still the lowest component in the rest of
the phantom. As in almost all of the dose profiles, the gamma dose stays fairly constant
throughout the depth of the phantom. The fluctuations in the gamma dose component,
most prominent in Figure 5.10(c), are due to poor statistics. The uncertainty in the gamma
dose was approximately 20% at the surface of the phantom. It then increased in the middle
of the phantom to about 40%, only to decrease towards the end of the phantom to between
20 and 30%. Uncertainty in the boron, thermal and nonthermal neutrons remained below
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Figure 5.10 Dose per depth in phantom for ideal isotropic
beams energies of (a) 1 eV, (b) 5 eV and (c) 10 eV.
As expected, the nonthermal neutron contribution becomes stronger with increasing neu-
tron beam energy such that at 75 eV, the nonthermal neutron dose is close to the gamma
dose and in the phantom it is comparable to the thermal and boron doses (Figure 5.11).
This behavior is similar to that seen with monodirectional beams. Again, the fluctuations
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in the gamma dose are due to poor statistics since few but very energetic capture gammas
are generated in the phantom.
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Figure 5.11 Dose per depth in phantom for ideal isotropic
beams energies of (a) 25 eV, (b) 50 eV and (c) 75 eV.
Poor statistics in the gamma dose is a common feature of all the plots, despite the fact that
40 million particle histories were run, compared with 1 million particle histories with the
monodirectional source. The reason that so many more are required in the isotropic beam
" . .. I . i "" . I .  i
0 1 2 3 4 5 6 7 8 9
Depth (cm)
75 eV Isotropic Beam
| 3tarl
WOe
.~
r
11 I6 . II
-~·--·-· '
r
r
p
-I- Gamma
-0- Thermal
-V- Nonthermal
-0- Boron
-3- Gamma
-0- Thermal
Nonthermal
- Boron
-0- Gamma
-0- Thermal
- Nonthermal
Boron
studies is that many of the particles don't even enter the phantom since they are emitted at
all angles from the plane of the source.
Figure 5.12 shows the dose per depth in a phantom for ideal isotropic beam energies of
100 eV and 125 eV. Again, similar to the monodirectional beams at these energies, the
nonthermal dose component has increased and is comparable to the gamma-ray dose at the
phantom surface.
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In the next set of figures, Figure 5.13 (a) (b) and (c), the point at which the nonthermal
neutron dose becomes larger than the gamma, thermal or neutron doses at the surface of
the phantom is identified. At 250 eV, the nonthermal neutron dose is equal to the gamma
dose at the surface of the phantom and is slightly higher than the thermal neutron dose in
the phantom itself. At 500 eV, however, the nonthermal neutron dose has surpassed the
gamma dose to the surface of the phantom, Figure 5.13(b), and is equal to the gamma dose
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Figure 5.12 Dose per depth in phantom for ideal isotropic
beams energies of (a) 100 eV and (b) 125 eV.
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at the synovium. In the phantom, the nonthermal dose is approaching the level of the
gamma component which shows the highest dose rate.
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Figure 5.13 Dose per depth in phantom for ideal monodirectional
beams energies of (a) 250 eV, (b) 500 eV and (c) 750 eV.
In the final two energies tested, 1 keV and 10 keV, shown in Figure 5.14, the nonthermal
dose component grew such that by 10 keV, the nonthermal dose was comparable to the
boron dose to the synovium which was loaded with 400 ppm of '0B. For 10 keV, the num-
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ber of particle histories was increased from 40 million (used for the entire study) to 100
million in order to decrease the fluctuations the gamma dose. The graph in Figure 5.14(b)
is the result using 100 million particle histories.
The average gamma contribution to the capsule, i.e. from the surface of the phantom to a
depth of 1.1 cm, was 1% while the thermal and boron dose contributions were approxi-
mately 0.1% and the nonthermal dose contribution comprised the rest. The average contri-
butions of the different components to the bone (only considering the "front half', from a
depth of 2.0 cm to 4.5 cm) were approximately 6% for the gamma, 0.6% for the thermal
neutrons, 0.6% for the boron and 93%(rounding off) for the nonthermal neutrons.
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Figure 5.14 Dose per depth in phantom for ideal monodirectional
beams energies of (a) 1 keV and (b) 10 keV.
5.1.3 Therapeutic Usefulness Ratios
Determination of the therapeutic usefulness of the monoenergetic beams was carried out
by examining the ratio of synovium dose to healthy tissue dose for all the tissues in the
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phantom. First, total dose was determined by summing all the dose components. The ratio
of the total synovial lining dose to the healthy tissue dose was then calculated for all tissue
layers and for all beam energies.
Table 5.1 shows the ratios of the synovium dose to capsule dose for the monodirectional
and isotropic sources. The range of values is derived from the existence of 4 tally regions
contributing to the capsule in the computational model.
Table 5.1: Ratio of Synovium Dose to Capsule Dose
Monodirectional Isotropic
Energy (eV) Average Range Average Range
0.025 88 75- 101 52 50- 53
0.1 94 78 -112 58 53 -62
1 101 81-122 79 70-87
5 102 81-125 72 64-79
10 106 83- 129 82 70- 106
25 102 79- 125 86 72- 103
50 97 78 -119 87 77 -98
75 93 75 -112 70 62 -78
100 90 72- 110 80 77-84
125 84 68- 101 70 62-79
250 66 59-75 48 45-52
500 45 42-49 39 33-45
750 32 34- 31 21 18- 24
1,000 23 23-24 15 13-17
10,000 2 2-2 2 1-2
The values show a similar pattern of increasing to a plateau around 1 eV, with a slight peak
around 10 eV, and decreasing sharply after 100 eV, as seen more clearly when plotted in
Figure 5.15. In this figure, the average value is plotted and the ranges are indicated by the
vertical bars (i.e. these are not "error bars").
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Figure 5.15 Ratio of Synovium Dose to Capsule Dose for different beam
energies using both (a) monodirectional and (b) isotropic beams.
The values for the isotropic beam study are considerably lower than the monodirectional
beam study until the 1 keV and 10 keV energies where the values are almost the same. The
shape of the curve for the isotropic beam study is not as smooth as for the monodirectional
study, as can be seen particularly in the plateau regions of the curves shown in Figure
5.15. This is probably due to statistical fluctuations.
The ratio of synovium dose to subsynovium dose using both monodirectional and isotro-
pic beams is shown in Table 5.2. Again there is a range of values because the subsyn-
ovium had more than one tally region. The subsynovium, 0.3 cm thick, was divided into
two tally regions 0.15 cm each.
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Table 5.2: Ratio of Synovium Dose to Subsynovium Dose
Monodirectional Isotropic
Energy (eV) Average Range Average Range
0.025 64 61 -68 51 50 -53
0.1 64 60-69 49 47-52
1 65 60-70 67 62-72
5 66 61-71 52 48-56
10 67 61-72 65 60-71
25 63 58 - 68 58 53 - 64
50 63 59-68 57 51-66
75 61 56-66 49 47-52
100 59 54 -64 65 62 -68
125 56 52-60 57 55-59
250 50 47- 54 32 30- 35
500 38 37 -40 42 40 -45
750 30 29- 30 25 25- 26
1,000 22 22-22 17 17-17
10,000 2 2-2 2 2-2
As in the ratio of synovium dose to capsule dose, the values from the isotropic beams are
lower than the values of the monodirectional beams. The average value of the ratio has
decreased from the corresponding values in the previous table which listed the synovium
dose to capsule dose for all energies. The decrease applies to all neutron energies except
the monodirectional and isotropic energies of 10 keV where the value remained the same.
The values in Table 5.2 are shown in figure 5.16. Again, the average value is plotted and
the vertical bars indicate the higher and lower value (since the subsynovium is only
divided into two tally regions).
Ratio of Synovium Dose to Subsynovium Dose vs. Monodirectional Beam Energy
80 -.. .
60
40 -
0 --
0.01 0.10 1.00 10.00 100.00 1000.00 10000.00
Energy (eV)
Ratio of Synovium Dose to Subsynovium Dose vs. Isotropic Beam Energy
80
60-
40 .
20 --• .......
O q--. ... x-,-¢
0.01 0.10 1.00 10.00 100.00 1000.00 10000.00
Energy (eV)
Figure 5.16 Ratio of Synovium Dose to Subsynovium Dose for different beam
energies using both (a) monodirectional and (b) isotropic beams.
In the monodirectional beam case, the average value remains fairly constant between
0.025 eV and 10 eV, although the range of values increases. The ratio then begins to
decrease with the sharpest decrease beginning at 100 eV. In the isotropic beam case, the
average ratio oscillates between 50 and 65 (approximately) between 0.025 and 100 eV,
after which it suffers a sharp decrease with the exception of the small increases at the 750
eV energy. The sharp decrease begins at 100 eV for both monodirectional and isotropic
beams. The ratio is reduced to the same value for both beam types by 10 keV.
The next table, Table 5.3, shows the average values for the synovium dose to fluid space
dose. Here there is no range because the fluid space, 0.2 cm thick, was tallied in one region
only.
0
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Table 5.3: Ratio of Synovium Dose to Fluid Space Dose
Energy (eV) Monodirectional Isotropic
0.025 62 55
0.1 54 49
1 46 55
5 45 40
10 45 40
25 46 46
50 45 36
75 44 46
100 46 39
125 44 38
250 39 35
500 34 42
750 27 28
1,000 23 18
10,000 3 4
The values of the synovium dose to fluid space dose for the monodirectional and isotropic
beams are closer than the ratios for previous tissues, capsule and subsynovium. There is a
small increase between the synovium to subsynovium ratio and the synovium to fluid
space at for the 1 keV and 10 keV energies of both monodirectional and isotropic beam
energies.
The results from Table 5.2 are plotted in Figure 5.17. A different type of behavior emerges
in the plot of the monodirectional beam case. The ratio begins at a high of approximately
60 and then decreases to a plateau between 1 and 100 eV, after which it begins to decrease.
The ratios for the isotropic beam case, on the other hand, exhibit the same behavior as the
ratio of synovium dose to subsynovium dose. It should be emphasized that in both the
monodirectional and isotropic beam cases, the sharp decrease in synovium dose to fluid
space dose, as in the other ratios plotted thus far, begins after 100 eV.
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Figure 5.17 Ratio of Synovium Dose to Fluid Space Dose for different beam
energies using both (a) monodirectional and (b) isotropic beams.
As before, the ratio of synovium dose to fluid space dose is smooth with monodirectional
beams whereas it oscillates with the isotropic beams, a phenomenon most likely due to
statistical fluctuations.
Following the tissue layers in the cylindrical joint phantom, the next (and second to last)
ratio to be considered is the ratio of synovium dose to articular cartilage dose. Attention
needs to be paid to this ratio particularly in light of the fact that, as was mentioned in the
introduction, very little articular cartilage destruction is necessary to weaken normal joint
function causing progressive and irreversible articular cartilage disintegration. In fact, one
of the motivations behind removing the synovium (besides the fact that its increased size
''
causes a painful increase in joint pressure), is to stop its destruction of articular cartilage
by preventing the secretion of particular cytokines and enzymes. Table 5.4 lists the values
of the ratio of synovium dose to articular cartilage dose. Again, as in the subsynovium,
there is no range because the articular cartilage (0.2cm thick) was tallied in one region
only.
Table 5.4: Ratio of Synovium Dose to Articular Cartilage Dose
The trends in this ratio, which are more easily seen when plotted (see Figure 5.18), differ
from the previous ratio. In the monodirectional beam case, the ratio of synovium dose to
articular cartilage dose follows the same trend as for the fluid space, i.e. it starts at a rela-
tively high value and then decreases to a plateau between 1 an 100 eV, after which it suf-
fers a sharp decrease. The first two ratios in the isotropic beam case are similar to the
Energy (eV) Monodirectional Isotropic
0.025 69 65
0.1 59 56
1 49 59
5 48 44
10 49 42
25 48 51
50 48 51
75 46 47
100 48 37
125 46 33
250 42 35
500 36 44
750 29 29
1,000 24 27
10,000 3 5
monodirectional case. However, it remains at approximately the same value for 1 eV and
then slopes up and down before a clear cut decrease after 1 keV. Since there is only one
tally region and cell, relatively small in size, a large uncertainty in the gamma component,
which as shown before, is dominant until approximately 500 eV could have a large effect
on the ratio.
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Figure 5.18 Ratio of Synovium Dose to Articular Cartilage Dose for different
beam energies using both (a) monodirectional and (b) isotropic beams.
The final healthy tissue to be considered is the bone. The synovium dose to bone dose
ratios are listed in Table 5.5. Special attention also needs to be paid to the bone since the
bone surface has been identified by the International Commission on Radiation Protection
Report 26 (ICRP, 1977) as a principal radiosensitive target to be protected in procedures
involving bone irradiation. Again, since the bone was divided into ten tally regions, in
order to obtain detailed dose profiles in the phantom, both the range and average values
are given for each energy.
It must be noted that the size of the range could be related to the size of the last tally region
of the bone which is very small. This small size results in larger uncertainty, particularly in
the isotropic beam case, which can cause fluctuations in the value found in that specific
tally region and thus increase the value of the upper region.
Table 5.5: Ratio of Synovium Dose to Bone Dose
Monodirectional Isotropic
Energy (eV) Average Range Average Range
0.025 90 73 -106 76 64- 91
0.1 71 61 - 83 64 55-97
1 55 51-58 71 58-78
5 53 48-56 58 51 -100
10 54 50-57 54 38-99
25 54 49-61 70 51-96
50 53 49-55 67 49-92
75 51 46-56 57 40- 119
100 52 48-56 65 49-97
125 51 46-55 57 39-68
250 45 41-52 46 31-115
500 38 33-44 42 33-62
750 32 29- 37 38 33- 51
1,000 28 25-31 38 30-51
10,000 4 3-5 6 5-9
The highest average value of the synovium dose to bone dose ratio for both the monodi-
rectional and isotropic beam energies occurs at 0.025 eV. As Figure 5.19 indicates, the
average value of the ratio increases in the monodirectional case as energy decreases and
reaches a plateau at 1 eV until approximately 100 eV where the ratio begins to drop
sharply. In the isotropic beam energy case the average of the ratio oscillates (again due to
statistical fluctuations) between approximately 75 and a low of approximately 54 before it
begins a course of sharp decrease after 100 eV.
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Figure 5.19 Ratio of Synovium Dose to Bone Dose for different beam
energies using both (a) monodirectional and (b) isotropic beams.
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Ideal neutron beam studies have demonstrated that low energy neutrons, roughly in the
range from thermal energies to 100 eV, will provide the highest therapeutic ratio in BNCS.
This energy range, therefore, will represent a design goal in studies aimed at modelling a
useful therapy beam for a practical neutron source. Also, before turning to another topic, it
must be noted that the magnitude of these ratios are high compared to conventional BNCT
where concentrations of the boron compound achieved in the tumor are only about ten
times higher than those in healthy tissue resulting in therapeutic ratios ranging from about
2 to 10 as reported in the ideal beam study to determine the optimal neutron energy range
for BNCT (Yanch et al, 1991).
5.2 Figure of Merit
The formulation of the Figure of Merit was prompted by a desire to evaluate possible
assemblies in air rather than in a phantom thereby reducing the required computation time.
As part of the process in developing the Figure of Merit, a preliminary moderator/reflector
configuration was established. The geometry was chosen based on a previous finding that
the optimal moderator and reflector geometry is cylindrical and that the insertion of the
target a few centimeters into the moderator greatly increases the available neutron flux
(Yanch et al, 1992). The rationale behind the material selection and the dimensions will be
discussed in sections 5.3.1 and 5.3.2. The focus of this section will be the development
and test of the Figure of Merit and its test by comparison of the results with those obtained
in a phantom.
5.2.1 Formulation
The geometry used is shown in Figure 5.20. An extra surface was placed 1 cm away from
the moderator end in order to simulate the relative position of a joint phantom.
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Figure 5.20 Moderator/Reflector configuration with an extra tally surface added
during the evaluation of the configuration using the developed figure of merit.
The flux was divided into bins representing the energies tested in the ideal beam studies.
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The flux in each bin was weighted by the average ratio of synovium to capsule dose and
then normalized by the total neutron flux over the entire extra surface. Weighting was also
done using the synovium to bone dose. The difference by the weightings of the different
ratios and different neutron source distributions were examined.
Two moderator/reflector configurations were tried. The first configuration which will be
denoted by M/R #1 had the following dimensions: moderator diameter 24 cm and length
of 21 cm; reflector thickness of 18 cm and length 26 cm. The second configuration which
will be denoted by M/R #2 had the following dimensions: moderator diameter 15 cm and
length 50 cm; reflector thickness 18 cm and thickness 55 cm. Both configurations used the
spectrum for 2.5 MeV protons on a lithium target. In both cases, the moderator material
was heavy water and the reflector material was graphite. Results are shown in Table 5.6.
Table 5.6: Evaluation using Figures of Merit
Ratio used forIdeal Beam Study Ratio used for M/R #1 M/R #2Figure of Merit
Monodirectional Syn/Capsule 53 91
Syn/Bone 73 78
Isotropic Syn/Capsule 51 56
Syn/Bone 53 69
As expected, the Figures of Merit using the monodirectional weightings were higher than
those using the isotropic weighting. The difference in the M/R #1 using the synovium dose
to capsule dose weighting (Syn/Capsule) is similar for the monodirectional and isotropic
cases, giving 53 and 51 as Figures of Merit, respectively. A greater discrepancy exists in
using the synovium dose to bone dose weighting (Syn/Bone), yielding Figures of Merit of
91 versus 56. The situation is reversed for the M/R #2 where the greater discrepancy
occurs between the Syn/Capsule of the beams, i.e. Figures of Merit of 91 versus 56 for the
monodirectional and isotropic, respectively, rather than the Syn/Bone, i.e. Figures of Merit
of 78 versus 69 for monodirectional and isotropic, respectively.
5.2.2 Evaluation in Phantom
The validity of the figure of merit described above was tested in the phantom model
described in the ideal beam studies. The cylindrical joint phantom was simply inserted
into the moderator/reflector geometry with the tally region oriented towards the moderator
end, as shown in Figure 5.21. The dose per depth in the phantom and ratio of synovium
dose to healthy tissue dose was determined in the same way as was outlined in section 5.1
and compared to the Figure of Merit developed in section 5.2.1.
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Figure 5.21 Geometry for evaluation of figure of merit in a phantom.
The two moderator/reflector configurations evaluated with the Figure of Merit in Section
5.2.1 were run with the cylindrical joint phantom. The ratios of synovium dose to capsule
dose and synovium dose to bone dose were determined in the same manner that they were
determined for the ideal beam study. The results for the runs with the phantom are given in
the following table, Table 5.7, for comparison with the values in Table 5.6.
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Table 5.7: Evaluation using joint phantom
Syn/Capsule Syn/Capsule Syn/Bone Syn/Bone
Average Range Average Range
M/R #1 23 21 -24 33 29 -41
M/R #2 61 59 - 64 67 57 - 73
As can be seen in Table 5.7, both the average ratios of synovium dose to capsule dose and
of synovium dose to bone dose for the M/R #1 were grossly overestimated using any of
the Figure of Merits presented in Table 5.6. The values were closer for the M/R #2, partic-
ularly for the value of the Syn/Capsule ratio, but were still not the same.
The average Syn/Capsule ratio for the M/R #1 calculated in the joint phantom is 23, about
half of the value predicted by the Figure of Merit with the monodirectional beam study
weighting, i.e. a value of 53. The isotropic beam study weighting for the figure of merit
gave a somewhat lower value of 51. Thus, weighting by the isotropic ideal beams yielded
a slightly closer result using the Syn/Capsule weighting ratio. The difference in results
between the Figure of Merit and the phantom runs was more apparent with the Syn/Bone
weighting. The monodirectional beam weighting gave a Figure of Merit of 73, more than
twice the average of given by a run with a phantom, i.e. 33. The isotropic weighting gave
a closer value at 53, less than half as much.
The figures of merit using the isotropic and monodirectional beam study weightings fared
better in the ratios for M/R #2. They were nearer to the values obtained by the Figure of
Merits, though still not the same. The average Syn/Capsule ratio given in Table 5.7 for the
M/R #2 is 61 which is higher than the figure of merit using the isotropic weightings (56)
and lower than that using the monodirectional beams (78). Neither figure of merit is
within the range given by the run with the joint phantom. However, the value obtained for
the Syn/Bone using the isotropic weighting, 69, is within the range of the Syn/Bone using
a joint phantom, which ranges from 57 - 73.
Figure 5.22 shows the dose per depth profiles using both the M/R #1, Figure 5.22(a), and
M/R #2, Figure 5.22(b). As expected, the dose rate for M/R #1 is higher than M/R #2. In
fact, as seen in Figure 5.22, the dose rate is generally two orders of magnitude higher for
all components except the nonthermal neutron dose. For the M/R #1, the nonthermal dose
is greatest at the surface of the joint phantom until a depth of about 2 cm, at which point it
is comparable to the gamma dose. As moderator length and diameter increased, M/R #2,
the nonthermal neutron dose decreased such that it is an order of magnitude lower than the
thermal and boron doses.
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Figure 5.22 Plots showing the profiles of dose per depth in the joint
phantom for (a) M/R #1, described both in the figure itself and the
preceding paragraph and (b) M/R #2, also described in the figure and
preceding paragraph.
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The evaluation of the Figure of Merit in a phantom has shown that the results obtained
using the Figure of Merit do not necessarily coincide with the actual synovium dose to
," ~. "'
healthy tissue dose as calculated in a phantom. Therefore, in order to obtain accurate ratios
of synovium dose to healthy tissue dose, it is recommended that the Figure of Merit not be
used and the phantom be inserted in the moderator/reflector geometry.
5.3 Target Selection
Of the possible accelerator targets for the production of neutrons, the 7Li(p,n)7Be reaction
has received considerable attention by BNCT investigators (e.g. Yanch et al 1992, Wu et
al 1993). This has been the target of choice owing to its relatively low neutron energies
and high neutron yields (Shefer, 1990). These characteristics are due to the presence of a
large cross-section resonance, 580 mb, at 2.25 MeV which is just above the proton thresh-
old energy of 1.88 MeV. The neutrons in this reaction are preferentially emitted in the for-
ward direction. Also, the low threshold implies that the proton beam power is low for a
given proton current and that the energy per proton to be dissipated is relatively small
(Shefer, 1990). The total neutron yield for this reaction is 8.96x10 11 n/s per mA.
However, some practical disadvantages to lithium targets. For example low melting point
and low thermal conductivity, have prompted the investigation of beryllium as alternate
target material, i.e. via the reaction 9Be(p,n)9Be. Disadvantages to the use of this latter
reaction included the lacuna of knowledge of the low energy end of the spectrum. This has
recently been corrected by the work of Howard et al (Howard, 1996). In order for the
beryllium target to be used, a higher proton energy, 4.0 MeV, must be applied to the target
than with a lithium target. The total neutron yield for the beryllium reaction is slightly
higher than the lithium reaction at 1.51x1012 n/s per mA.
In light of the results of the evaluation of the evaluation of the Figure of Merit in the joint
phantom, the two target materials, lithium and beryllium, were evaluated using the joint
phantom and several moderator/reflector configurations, which will be described below.
The moderator diameter was kept constant at 15 cm, the reflector thickness at 18 cm and
the reflector length at 5 cm greater than the moderator length which was sequentially set at
20 cm, 35 cm and 50 cm. The proton energy on the lithium target was modelled as being
2.5 MeV and on the beryllium target as 4.0 MeV. For both targets, a 4 mA proton current
which is achievable in the tandem electrostatic accelerator constructed at MIT LABA, was
used for the determination of the total neutron yield for each reaction. Thus, for the lith-
ium target the total neutron yield was calculated to be 3.6x1012 n/s, while for the beryllium
target it was calculated to be 6.04x1012 n/s.
5.4 Moderator/Reflector Assembly
It must be noted that the data acquired did not fill a three dimensional space but rather a
one dimensional space. A three dimensional investigation would require that, for example,
for every change in diameter of the moderator, simulations be run for all different lengths
modelled. In a one dimensional study, on the other hand, the diameter of the moderator
was arbitrarily chosen and only the length varied. This was deemed acceptable on the
assumption that the diameter dependence for other lengths should have a similar shape
and characteristics with the exception of a scaling factor. One set of data was acquired to
check this assumption.
5.4.1 Material Selection
This section will present the criteria and selection of materials for the components of the
neutron beam design, i.e. moderator and reflector. Issues such as patient shielding were
not considered in this investigation. The selection of materials presented here is based on
the work of Yanch et al for the design of an epithermal accelerator based beam for BNCT
(Yanch et al, 1992) but adapted for BNCS.
Several criteria exist for choosing an optimum moderator material. One is that the material
have a large scattering cross section and a small mass number, to enable a great deal of
energy loss in a small amount of space. Another requirement is that it have a greater prob-
ability of interaction with fast neutrons than thermal or epithermal neutrons, preventing
the output neutron spectrum from being saddle-shaped and fast neutrons contaminating
the beam. An optimal moderator also helps the beam maintain a forward direction. A light
isotope is desirable because isotropic scattering in the center-of-mass system transforms to
a more forwardly biased scattering in the lab system. Finally, capture gamma production
must be low so that gamma shielding does not have to be placed between the moderator
and the patient.
A detailed investigation was made by Yanch et al (Yanch et al, 1992) on the following
materials: alumina, beryllium oxide, titanium deuteride, light water and heavy water. Of
these five materials, it was found that three of them, i.e. alumina, titanium deuteride and
light water produced a significant number of energetic capture photons. They were thus
excluded as potential moderator materials. The other two, heavy water and beryllium
oxide, were somewhat similar in their moderating abilities. Heavy water was chosen as the
moderating material for BNCT because it maintained a higher flux of epithermal neutrons,
desirable for BNCT, and had the advantage of being much less toxic and less expensive to
handle than beryllium oxide. The fact that heavy water maintains a higher epithermal flux
of neutrons is not of interest for the design of a neutron source for BNCS because the
desired flux of neutrons is primarily thermal. heavy water may be better for thermal neu-
trons as well since the Z is smaller. This, combined with the consideration that heavy
water is less toxic than beryllium oxide, led to the choice of heavy water as the moderator
for BNCS.
Generally, the purpose of placing a reflector around the moderator is to improve the yield
of therapy neutrons at the patient position (Yanch et al, 1992). Energetic neutrons trying to
leave the moderator in places other than the patient position can be scattered by the reflec-
tor back into the moderator and thus can become therapy neutrons again. In order for a
material to be a good reflector, it should be a heavy isotope because it will avoid excessive
neutron energy losses in the process described above (in which case the neutrons may be
so thermalized that they will not make it to the moderator end). Also, the heavy isotopes
stop gammas thus effectively improving the purity of the beam with respect to gamma
contamination and reducing the background dose.
The reflectivity of several materials, namely lead, bismuth, graphite and alumina, was
investigated in previous work (Yanch et al, 1992) and the relevant results are summarized
below. Lead, graphite and alumina all had similar reflectivity whereas bismuth was less
reflecting. In terms of gamma production, graphite was seen to be the cleanest while alu-
mina the most contaminating. Lead and bismuth fell somewhere in between. For the epith-
ermal beam design, Yanch et al chose lead because graphite was considered too
moderating. However, for BNCS, increased moderation is desirable since, as will be
shown in the results of the ideal beam studies in the following chapter, BNCS requires a
thermal neutron beam.
5.4.2 Geometry
The proposed geometry for the moderator/reflector assembly, consisting of two cylinders,
is shown in Figure 5.22. This time the tallies were taken across the surface of the end of
the moderator cylinder (inside the reflector cylinder). The neutron spectrum was that of
2.5 MeV protons hitting a lithium target 5 cm in diameter and 1 cm in thickness.
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Figure 5.22 Moderator/reflector configuration of neutron beam for BNCS.
For all simulations, particle flux of all components, i.e. thermal neutrons (neutrons with a
cutoff energy of 0.36 eV), nonthermal neutrons (neutrons with energies above 0.36 eV)
and photons, was obtained across the surface of the moderator end. In order to obtain dose
rates, both neutron and photon fluxes were modified with the fluence-to-kerma conversion
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factors of Caswell et al (Caswell, 1982) and Zamenhof et al (Zamenhof, 1975).
The dependence of dose and flux of thermal neutrons, nonthermal neutrons and gammas
on moderator length and diameter were examined sequentially. Keeping the moderator
diameter fixed at 15 cm, the moderator length was varied from 20 to 60 cm in increments
of 5 cm. Then, keeping the moderator length fixed at 45 cm, the diameter was varied from
10 to 24 cm, specifically from 10 cm to 15 cm in increments of 1 cm and then 18 cm and
24 cm. The percent contributions of the different components were examined in order to
maximize the favorable and minimize the unfavorable components. Reflector thickness
was kept at 15 cm and the length was fixed to be 5 cm longer than the moderator.
In a separate set of runs, the reflector thickness was varied from 5 cm to 24 cm while the
moderator length was kept at 45 cm and the diameter at 15 cm. The reflector length was
kept coupled with the moderator length. The effect of the added length of the reflector
length was tested by keeping all other parameters constant and changing the added length
from 5 cm to 15 cm.
6 Neutron Beam Design: Results
6.1 Target Selection
This section will present a comparison between beryllium and lithium neutron-producing
targets using a geometry that includes the cylindrical joint phantom with several potential
moderator/reflector configurations. The difference in the potential moderator/reflector
configurations lies in the length of the moderator which is set at 20, 35 and 50 cm.
Before presenting the results, a brief review of the parameters used in this comparison is
given. The moderator diameter was kept constant at 15 cm, the reflector thickness at 18
cm and the reflector length at 5 cm greater than the moderator length. The proton energy
on the lithium target was modelled as being 2.5 MeV and on the beryllium target as 4.0
MeV. For both targets, a 4 mA proton current, achievable in the tandem cascade accelera-
tor constructed at MIT LABA, was used for the determination of the total neutron yield
for each reaction. Thus, for the lithium target the total neutron yield was calculated to be
3.58x1012 n/s and for the beryllium target it was calculated to be 6.04x1012 n/s.
Table 6.1:Comparison of Beryllium and Lithium Targets
Target: Syn/Capsule Syn/Capsule Syn/Bone Syn/Bone
Mod. Length Average Range Average Range
Lithium: 17 16-17 27 21-30
20 cm
Beryllium: 10 9 - 10 15 13 - 17
20 cm
Lithium: 59 55 - 66 55 50- 61
35 cm
Beryllium: 46 42- 50 50 45 - 78
35 cm
Lithium: 61 59-64 67 57-73
50 cm
Beryllium: 57 53 - 63 60 53 - 67
50 cm
The dose profiles for these neutron beams are provided in Figures 6.1 through 6.3, divided
by moderator length. The first dose profile shows the 20 cm moderator long moderator for
both the lithium and beryllium targets. In addition to the Syn/Capsule ratio and Syn/Bone
ratio, it is instructive to see the dose profiles.
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Figure 6.1 Figure showing the difference in dose profiles of a
(a) lithium and (b) beryllium target using a heavy water moderator
of length 20 cm, diameter 15 cm, and graphite reflector of length 25 cm
and thickness 18 cm.
As Figure 6.1 shows, the dose rate due to nonthermal neutrons is lower in the lithium tar-
get rather than the beryllium target. Using the lithium target, the nonthermal dose would
not be very much higher than the gamma dose whereas using the beryllium target would
yield a nonthermal dose larger than the gamma dose which is similar using both targets.
The thermal neutron and boron dose rates are comparable and show the same profile using
both targets.
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The next figure, Figure 6.2, shows the differences between lithium and beryllium targets
using a 35 cm long moderator. The other parameters of the moderator/reflector configura-
tion are the same as previously.
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Figure 6.2 Figure showing the difference in dose profiles of a
(a) lithium and (b) beryllium target using a heavy water moderator
of length 35 cm, diameter 15 cm, and graphite reflector of length 25 cm
and thickness 18 cm.
Although the gamma dose is similar, the thermal and nonthermal neutron and boron dose
rates are higher for the beryllium target rather than the lithium target. With the lithium the
thermal neutron, nonthermal neutron boron dose components remain below 0.01 rad/s
while with beryllium they are all hovering around 0.02 rad/s. Through the phantom, the
nonthermal neutron dose is almost an order of magnitude higher with the beryllium target
rather than the lithium target. However, it must be noted that at this particular length, the
nonthermal is always smaller than the gamma dose rate which is not as easy to reduce in
that it includes the gamma dose due to induced photons.
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The next set of plots, Figure 6.3, shows the difference in dose profiles of a lithium and
beryllium target but this time using a moderator with a length of 50 cm.
Lithium Target; Moderator length 50 cm
x1 11x10
-0- Gamma
-0-Thermal
X-- Nonthermal
xiU. O- Boron
lxlO "-
1x10 I I
0 1 2 3 4 5 6 7 8 9 10
Depth (cm)
Beryllium Target; Moderator length 50 cm
1x101 -
-0- Gamma
-0- Thermal
-V- Nonthermal
-O- Boron
1 I I I I I I I I I
1 2 3 4 5 6 7 8 9 10
Depth (cm)
Figure 6.3 Figure showing the difference in dose profiles of a
(a) lithium and (b) beryllium target using a heavy water moderator
of length 50 cm, diameter 15 cm, and graphite reflector of length 25 cm
and thickness 18 cm.
The interesting thing that emerges from Figure 6.3 is that the gamma, thermal neutron and
boron doses are essentially the same with both lithium and beryllium targets. However, the
nonthermal neutron dose is an order of magnitude higher using the beryllium target rather
than lithium. The fluctuations in the nonthermal neutron dose using the beryllium target
are due to statistical noise.
6.2 Moderator/Reflector Assembly
As a first step the moderator length was varied from 20 to 60 cm in increments of 5 cm.
During this set of runs the moderator diameter was kept constant at 15 cm, the reflector
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thickness was also 15 cm and the reflector length was always kept 5 cm larger than the
moderator length. The source spectrum was that from 2.5 MeV protons hitting a lithium
target which was 5 cm in diameter and 1 cm thick. For the dose calculation, a total neutron
yield of 3.584x10'2 n/s was used. Figure 6.4 shows the change in the flux and dose with
moderator length and other parameters as described above.
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Figure 6.4 Plots showing the effects of changing moderator length
on (a) flux and (b) dose. The other parameters were as follows:
moderator diameter 15 cm. reflector thickness 15 cm with the length
always 5 cm greater than moderator.
As seen in Figure 6.4, the change in moderator length had a significant effect on the non-
thermal neutron flux and dose, as well as an effect on the thermal neutron flux. Around 30
cm, the thermal and nonthermal neutron fluxes were the same, after which the nonthermal
neutron flux decreased much more quickly than the thermal neutron flux. The gamma flux
remained roughly constant and at 55 cm it was equal to the nonthermal neutron dose. The
dose components were all equal at 35 cm, after which the gamma and thermal neutron
dose components remained relatively constant while the nonthermal neutron dose compo-
nent decreased rapidly.
Since the moderator length had such a pronounced effect on the dose components, the per-
cent contributions were plotted versus moderator length in Figure 6.5, in order to see them
more clearly. In fact from Figure 6.5(b), there appears to be a peak in thermal neutron dose
at 40 cm, something which was not clear from Figure 6.4(b).
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Figure 6.5 Plots showing the effects of changing moderator length
on the components of (a) flux and (b) dose. The other parameters were
as follows: moderator diameter 15 cm, reflector thickness 15 cm with the
length always 5 cm greater than moderator.
The next parameter varied was the moderator diameter. It was varied from 10 cm to 24
cm, with increments of 1 cm between 10 cm and 15 cm and then an increment of 3 cm
(total of 18 cm) and one increment of 6 cm (total 24 cm). The moderator length was fixed
at 45 cm. The reflector length and thickness were kept at 15 cm and 50 cm respectively.
The effects on flux and dose are shown in Figure 6.6.
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Figure 6.6 Plots showing the effects of changing moderator diameter on
the components of (a) flux and (b) dose. The other parameters were as
follows: moderator length 45 cm, reflector thickness 15 cm and length 50 cm.
As can be seen from Figure 6.6, changing the moderator diameter did not have significant
effects on dose and flux as changing the moderator length. The gamma flux remained con-
stant at 2% while thermal neutron flux increased about 80% to 90% and the nonthermal
neutron flux decreased accordingly. The dose contribution of the gamma rays oscillated
between 50% and 60% while the thermal neutron contribution oscillated between 30%
and 40%. The contribution of the nonthermal neutrons decreased smoothly from about
10% to 4%. There were no changes greater than 10% by varying the moderator diameter
at this length.
These two degrees of freedom in the moderator dimensions, i.e. diameter and length, were
also examined conjunctively, thus an acquisition of three dimensional data. Table 6.2 lists
the fluxes obtained for four moderator diameters at two moderator lengths while Table 6.3
C
Dose vs. Moderator Diameter
lists the dose rates for the same.
Table 6.2: Effect of Increasing Moderator Length and Diameter on Flux
Length:flux* diam:15 cm diam:18 cm diam:21 diam:24cm
40:gamma 1.39e-06 1.78e-06 1.34e-06 1.06e-05
40:thermal 7.65e-05 7.67e-05 7.62e-05 7.23e-05
40:nonthermal 2.09e-05 1.87e-05 1.67e-05 1.45e-05
45:gamma 1.27e-06 1.34e-06 1.19e-06 1.08e-06
45:thermal 5.18e-05 5.12e-05 5.08e-05 4.86e-05
45:nonthermal 1.87e-05 7.51 e-06 6.81e-06 5.83e-06
* units are (cm): (particles/cm 2)
Table 6.3: Effect of Increasing Moderator Length and Diameter on Dose
Length:dose* diam:15 cm diam:18 cm diam:21 diam:24cm
40:gamma 3.42e-03 3.55e-03 2.87e-03 2.38e-03
40:thermal 2.85e-03 2.90e-03 2.90e-03 2.77e-03
40:nonthermal 9.28e-04 8.63e-04 6.34e-04 6.46e-04
45:gamma 3.23e-03 3.01e-03 2.41e-03 2.68e-03
45:thermal 1.95e-03 1.95e-03 1.95e-03 1.88e-03
45:nonthermal 2.43e-04 2.30e-03 2.13e-04 1.78e-04
*units are (cm):(rad/s)
There are several trends to be noticed. One is the effect of changing the diameter on the
different components. For example, looking at the gamma contributions to both flux and
dose across the diameters, first at 40 cm and then at 45 cm, it can be seen that the gamma
flux and dose decrease with increasing diameter for both the 40 and 45 cm cases, while the
thermal flux dose and flux at both 40 and 45 cm remains the same.
Then choosing a moderator diameter of 15 cm and length of 35 cm, the dimensions of the
reflector were varied. First, the reflector thickness was varied from 5 cm to 24 cm, in
increments of 5 cm between 5 cm and 15 cm and then in increments of 3 cm until 24 cm.
The reflector length was kept at 50 cm, i.e. 15 cm greater than the moderator length. The
results are shown below in Figure 6.7.
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Figure 6.7 Plots showing the effects of changing reflector thickness
on the (a) flux and (b) dose. The other parameters were as follows:
moderator diameter 15 cm and length 35 cm; reflector length 50 cm.
The flux of the various components increases until 18 cm, after which each plateaus at its
own value; approximately 1.6x10 -4, 5.3x10 .5 and 4.510-6 particles/cm'2 for the gamma rays,
thermal and nonthermal neutrons respectively. The change in flux for all components is
less than 2% after the 18 cm mark. The shapes of the gamma and thermal doses follow
those of the flux while the shape of the nonthermal neutron dose differs greatly; it is a
curve with a very small slope, making its percent contribution range from 65% to 18%.
The gamma dose increases by 4% and the thermal dose by 1%.
Since the reflector length was usually coupled with the moderator length, a comparison
was made between an increment of 5 cm or 15 cm. In other words, two configurations
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were tried where in one the reflector length was 5 cm more than the moderator and in the
other the reflector length was 15 cm more than the moderator length. The reflector thick-
ness was kept constant at 15 cm. The moderator diameter and length were fixed at 15 cm
and 35 cm, respectively. The results are summarized in the Table 6.4 below.
Table 6.4: Effect of Reflector Length on Flux and Dose
Increment of 5 cm Increment of 15 cm
particles/cm 2  particles/cm2
Flux Gamma 1.68e-06 2.46e-06
Thermal 1.11e-04 1.28e-04
Nonthermal 5.09e-05 5.17e-05
Dose Gamma 4.08e-03 6.30e-03
Thermal 4.03e-03 4.68e-03
Nonthermal 3.70e-03 4.02e-03
As can be seen in Table 6.4, the addition of 15 cm to the moderator length increased the
overall total flux and dose coming out of the moderator end, as well as shifting the relative
contributions. The gamma flux was increased by about 30% while both the thermal and
nonthermal neutron fluxes increased by about 15%. There were comparable increases in
the dose, i.e. the gamma dose increased by about 30%, while the thermal dose increased
by about 15% and the nonthermal by 10%.
7 Conclusion
This thesis had two major aims. The first was to analyze in vitro uptake of 'IB by samples
of Rheumatoid Arthritic synovium and Rheumatoid Arthritic and Osteoarthritic cartilage
in order to gain an estimate of the I'B levels potentially attained in vivo. The second was
to design an accelerator-based neutron beam for Boron Neutron Capture Synovectomy.
Conclusions and recommendations for future work relating to these two major aims will
be drawn sequentially in this chapter.
The in vitro analysis included three different parts. The first, and most extensive, was
quantification of bulk tissue uptake via Prompt Gamma Neutron Activation Analysis. The
second was an attempt to verify cell kill following thermal neutron irradiation of boron-
loaded tissue sample. The third was an attempt to spatially localize boron using Neutron
Induced Alpha Track Autoradiography.
The compound used, K2B12H,2, represented an attempt at finding an optimal compound for
BNCS which is non-toxic, remains sufficiently long in the joint space and delivers large
amounts of 'IB to the synovium. It must be emphasized again that this boron compound
contained natural boron which is 80% of "B and 20% of 'IB which implies that all the
concentrations reported in this thesis connected with the use of this compound could be
increased by a factor of five by using a compound 100% enriched in '0B.
Quantification of bulk '0B uptake in the form of K2B,2H,2 by RA synovium revealed that at
an incubation time of 1 hour and nominal incubation concentrations of 100 ppm, 500 ppm
and 1000 ppm, the average bulk tissue uptake was 33 ppm (range: 19 ppm to 42 ppm), 189
ppm (range: 79 ppm to 332 ppm), and 330 ppm (range: 190 ppm to 497 ppm), respec-
tively. Some discrepancies existed in these results, particularly in Table 4.4, where the
uptake of synovium when incubated at a nominal incubation concentration of 1000 ppm
for 24 hours was lower than expected (supposing that concentration always increases with
incubation time).
Results of the quantification of bulk tissue uptake corroborated preliminary investigations
of Johnson et al which found very high synovium uptake following incubation in boron
particulate and nominal concentrations of boric acid solution (Johnson et al, 1994).
Prompt Gamma Neutron Activation Analysis was a reliable and accurate means of boron
quantification.
As seen in Figure 4.1, there seemed to be an inverse relationship between uptake of some
compounds and the size of the sample. This could be due to limited diffusion distance of
the compound into the tissue. The limited diffusion distance into tissue would affect the
measurement of concentration in that the measurement is dependent on the B/H ratio
where the H is proportional to the size of the sample. If the sample were larger and limited
diffusion existed, then the H would increase while the B would remain constant making
the B/H ratio and consequently the concentration smaller. Differences in tissue type could
also result in different diffusion rates.
Results presented in Table 4.6 revealed encouraging results of RA cartilage uptake. The
average uptake of RA cartilage in this experiment was approximately a factor of ten lower
than the uptake in RA synovium (averaging 4 ppm for an incubation time of 1 hour and
nominal concentration of 100 pm and 42 ppm at an incubation time of 1 hour and nominal
concentration of 1000 ppm). Two other experiments, whose results are shown in Tables
4.4 and 4.5, were performed using the boron compound in varying concentrations. These
resulted in either unobtainable results (i.e. those results yielding negative concentrations)
or comparatively large uptake. This could be due size of the sample in relation to the vial.
Every vial is slightly different in size and when the background measurement is done, only
one vial is used as a representative of the set. This does not affect the B/H ratio when the
sample size is considerably bigger than the vial size. However, when the sample size is so
small compared to the vial, subtraction of background results in negative value which in
turn results in negative concentrations. It must be noted that the experiment providing the
encouraging results (Table 4.6) was performed with newly bought, homogeneous teflon
vials.
The aforementioned hypothesis relating sample size and uptake was also tested in bovine
cartilage which served as a substitute for OA and RA cartilage. As shown in Table 4.9, the
average uptake by the bovine cartilage was 617 ppm at an incubation concentration of
1000 ppm. This is 100 times larger than the cartilage results presented above. According
to the above hypothesis, the sample size should have been 100 times smaller. However,
the average sample size was 100 larger and thus in direct contrast with the hypothesis
relating sample uptake and sample size. However, it should be noted that differences could
exist between RA or OA and bovine cartilage, although they were expected to behave
similarly.
Unfortunately, the attempt to verify cell kill by the boron neutron capture reaction yielded
equivocal results. A possible reason for the lack of difference between the boronated and
the nonboronated irradiated samples was that no boron was present from the beginning.
The lack of difference between the set of irradiated and non-irradiated samples could be a
result of other dominating tissue processes, namely autolysis. Unfortunately, the complete
lack of results in Neutron Induced Alpha Track Autoradiography (due to experimental
problems) could not help address any of these issues.
Recommendations for future work include careful investigation of the toxicity of K2B 12H 2
and of the length of its stay in the joint, although it must be noted that a double-blind study
was conducted at the Royal Melbourne Hospital in Sydney, Australia suggesting that
boron is therapeutic for RA (Travers et al, 1990). This has been supported by another
study suggesting that a daily dose of boron is a safe and effective treatment for some
forms of arthritis (Newnham, 1994).
Other boron compounds should be analyzed in vitro in order to ensure that the optimal
compound form has been developed. After this, it is recommended to proceed to animal
studies using an antigen induced arthritis (AIA) model which bears close resemblance to
RA in humans and has been used extensively to assess potential radiation synovectomy
agents (Zuckerman, 1989). Animal studies yield information which can not be completely
simulated in vitro and thus are invaluable for determining the feasibility of BNCS.
The second aim of this thesis was to design an accelerator based neutron beam for BNCS.
Neutron beam design for BNCS is quite different from that of BNCT due to the shallow
depth of the synovium and the large concentrations readily achieved in the synovium as
shown earlier.
The monoenergetic, photon-free "ideal" beam studies indicated that the therapeutically
useful neutron energy range for BNCS is from 0.025 eV to 100 eV. This range represents
the energies at which the fast neutron dose is below the gamma dose which is a result of
interactions of neutrons with endogenous tissue.
After the therapeutically useful neutron energy range for BNCS was determined, attention
was turned to the development of a moderator/reflector configuration to achieve this range
from the energetic neutrons coming from an accelerator source.First, a Figure of Merit
was developed using the results of the ideal beam studies to weight the spectrum coming
out of the moderator end. If successful, the Figure of Merit would enable the determina-
tion of a therapeutically useful moderator/reflector configurations without the insertion of
the cylindrical joint phantom in the geometry. However, it was not found not reliable when
tested in a phantom.
The next step was to evaluate which of two neutron producing reactions, 7Li(p,n)7Be or
9Be(p,n)9Be, would be most appropriate for BNCS. The material which when irradiated
with protons produces neutrons, such as lithium and beryllium, is referred to as target
material. The lithium target consistently showed lower nonthermal neutron doses (except
at the moderator length of 35 cm where the lithium and beryllium nonthermal doses were
comparable) and higher average Synovium/Bone and Synovium/Capsule ratios. These
two tissue spaces were chosen because the capsule or the skin is the first point of contact
of the neutron beam. The bone was chosen in accordance with the identification of bone
surface as a principal radiosensitive area which is necessary to protect in procedures
involving bone irradiation (ICRP, 1977).
Materials for the moderator/reflector configuration were selected based on the findings of
Yanch et al while designing their neutron beam (Yanch et al, 1992). The material chosen
for the moderator was heavy water. For the reflector, graphite chosen because it had the
least gamma contamination and was found to be very moderating. In the neutron beam
design for BNCT, lead was used as the reflector material because graphite, although
cleaner with gammas, was considered too moderating. In BNCS, heavy moderation is
desired.
The dose and flux dependence on both the length and diameter of both the moderator and
reflector was investigated. The moderator diameter did not cause very large changes in
flux and dose between 10 cm and 24 cm. At 14 cm, there was a slightly lower gamma dose
than at other diameters. Increasing moderator length served to decrease the fast neutron
flux and dose while having almost no effect on the gamma dose and flux. In the range of
20 cm to 60 cm, the dose and flux components were equal at 35 cm, meaning that only
moderator lengths greater than 35 cm can give an increase of thermal neutrons over fast
neutrons. Interestingly, the peak percent contribution of thermal neutrons occurred at 40
cm. At this same moderator length, the gamma dose contribution was very close to the
thermal neutron. These results suggest that a moderator 14 cm in diameter and 40 cm in
length is optimal.
The increase in flux with increasing reflector thickness began to plateau after 18 cm, cor-
roborating previous findings (Yanch et al, 1992). The dose due to fast neutrons remained
the same at reflector thickness ranging from 5 cm to 25 cm. As seen in figure 6.7, dose
contributions of all components were the same at 10 cm, indicating at reflector thickness
greater than 10 cm is the absolute lowest threshold for reflector thickness. Since the
increase between 18 cm and 20 cm was not significant and the thermal neutron flux and
dose seemed to have reached a saturation point around 18 cm, it was decided that 18 cm
represented an optimal reflector thickness. The reflector length was generally coupled with
the moderator length. At a reflector thickness of 15 cm, the effect of the length of increas-
ing reflector length did not produce large changes in the flux and dose.
In order to give more perspective to this design, it must be mentioned that the intended
source of neutrons for BNCS is the 4.1 MeV, 4 mA tandem electrostatic linear accelerator
constructed in the MIT Laboratory for Accelerator Beam Applications (Yanch et al, 1995).
The advantages of this type of accelerator over other neutron producing sources include a
continuously tunable beam energy and proton current, the delivery of continuous current
to the target, the ability to operate at higher accelerating gradients for protons in the range
of 2-4 MeV, thus leading to a more compact system, high electrical power efficiency and
modest cooling requirements (Shefer et al, 1994). Its compact size would enable an easy
installation in a research or clinical environment (Yanch et al, 1993).
Future work will include the optimization of the moderator/reflector configuration and the
addition of shielding considerations (which have been ignored in this thesis). Other issues
will include consideration of therapy times (in order to deliver 10,000 rad to the synovium
as is done in radiation synovectomy) and the consideration of a multi-directional gantry
system. Ultimately, the moderator/reflector configuration for the MIT LABA accelerator
will need to be constructed for use in the animal studies.
Overall, results of this thesis indicate that BNCS has potential of becoming a new therapy
modality. High concentrations of ' 0B can be achieved in the synovium and a neutron beam
from an accelerator source of neutrons can provide the therapeutically useful neutron
spectrum.
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